Page last updated: 2024-08-22

angiotensin ii and Cardiovascular Diseases

angiotensin ii has been researched along with Cardiovascular Diseases in 382 studies

Research

Studies (382)

Timeframe	Studies, this research(%)	All Research%
pre-1990	12 (3.14)	18.7374
1990's	54 (14.14)	18.2507
2000's	168 (43.98)	29.6817
2010's	115 (30.10)	24.3611
2020's	33 (8.64)	2.80

Authors

Authors	Studies
Patrick, AC; Shridas, P; Tannock, LR	1
Chopada, K; Hati, S; Sakure, A; Shukla, P	1
Feng, Y; Geng, C; Li, Z; Tang, Y; Wang, J; Yang, H; Yang, Y; Zhao, H	1
Calus, E; De Deyn, PP; De Meyer, GRY; Hendrickx, JO; Van Dam, D	1
Asgharzadeh, F; Avan, A; Ferns, GA; Geraylow, KR; Hassanian, SM; Khazaei, M; Nassiri, M	1
Batlle, D; Danser, AHJ; Denton, KM; Geurts, F; Hassler, L; Hoogduijn, MJ; Hoorn, EJ; Koizumi, M; Li, XC; Lin, H; Matsusaka, T; Mirabito Colafella, KM; Nishiyama, A; Ramkumar, N; Zhuo, JL	1
Bu, S; Michels, DCR; Nguyen, HC; Nikfarjam, S; Patel, DA; Qadura, M; Rasheed, B; Singh, KK; Singh, R; Singh, S; Wang, L	1
Huang, W; Huang, Z; Li, W; Liang, G; Luo, W; Shen, S; Wang, M; Wu, G	1
Nguyen, J; Vandemark, C; Zhao, ZQ	1
Alves, AJ; Bertoquini, S; de Melo, JB; Figueiredo, D; Garcia, C; Guimarães, GV; Leitão, C; Lopes, S; Mesquita-Bastos, J; Oliveira, J; Pescatello, LS; Polonia, J; Ribau, V; Ribeiro, F; Ribeiro, IP; Teixeira, M	1
Liu, J; Zhou, G	1
Ferder, L; García Menéndez, S; Inserra, F; Manucha, W; Mazzei, L; Sanz, RL	1
Chang, CC; Cheng, HC; Chou, WC; Chu, PM; Hsieh, PL; Huang, YT; Lee, SD	1
Alla, JA; Langer, A; Nerger, E; Quitterer, U	1
Benndorf, RA; Dubourg, V; Gekle, M; Schreier, B; Schwerdt, G	1
Budhram-Mahadeo, VS; Clark, JE; Heads, RJ; Maskell, LJ; Mele, L; Stuckey, DJ	1
An, S; Cho, S; Jeong, J; Lee, J; Lee, M; Lim, J; Lim, S; Park, S; Seo, M; Yoon, N	1
Cui, Y; Rong, Q; Wang, C; Wang, F; Zhang, Y; Zhu, Y	1
Chen, DR; Chen, HJ; Chen, XH; Gao, PJ; Kong, LR; Pan, XX; Ruan, CC; Wu, F	1
Brown, TS; Cohen, JB; Hanff, TC; Harhay, MO; Mohareb, AM	1
Batthyany, C; Bresque, M; Caggiani, M; Calliari, A; Colman, L; Contreras, P; Escande, C; Leyva, A; Liechocki, S; Maya-Monteiro, CM; Mazal, D	1
Barakat, AG; Bezdicek, T; Chipman, JG; Ingraham, NE; Puskarich, MA; Reilkoff, R; Schacker, T; Tignanelli, CJ	1
Brooks, HL; Cannon, DK; Chen, H; Constantopoulos, E; Konhilas, JP; Lipovka, Y; Lopez-Pier, M; McKee, LA; Pollow, D; Regan, JA; Sanchez, JN; Skaria, R	1
Hrenak, J; Simko, F; Zorad, S	1
Autieri, MV; Corbett, CB; Okune, R; St Paul, A	1
Gan, R; Georgius, P; Henshaw, DJE; Noble, EP; Rosoman, NP; Sommerfeld, N	1
Bi, XY; Ding, YQ; Wang, PX; Ye, JT; Yu, YH; Yuan, J; Zhang, LL; Zhang, YH; Zhou, H	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Cicalese, S; Eguchi, S; Elliott, KJ; Hashimoto, T; Kawai, T; Okuno, K	1
Ahmad, S; Cheng, CP; Ferrario, CM; Groban, L; Sun, X; VonCannon, JL; Wang, H; Wright, KN	1
Grochot-Przęczek, A; Hajduk, K; Józkowicz, A; Klóska, D; Kopacz, A; Piechota-Polańczyk, A; Werner, E	1
Eguchi, S; Elliott, KJ; Kawai, T; Scalia, R	1
Bhatt, LK; Hussain, T; Raut, D; Selokar, I	1
Demura, M; Takeda, Y; Yoneda, T	1
Brits, SJ; Gafane-Matemane, LF; Kruger, R; Mels, CMC; Mokwatsi, GG; Schutte, AE; Smith, W; Uys, AS; Van Rooyen, JM	1
Hong, N; Lin, Y; Liu, W; Wang, Y; Xu, N; Ye, Z	1
Adachi, H; Berkowitz, DE; Biswas, D; Das, S; Dunkerly-Eyring, B; Flavell, RA; Henao-Mejia, J; Hori, D; Nomura, Y; Santhanam, L; Steenbergen, C; Steppan, J	1
Nakagami, H	1
Gong, WQ; Huang, WC; Liang, Y; Liu, B; Yang, CM; Ye, XL; Zheng, YT	1
Ferrario, CM; Mullick, AE	1
Islam, MZ; Miyamoto, A; Shiraishi, M; Van Dao, C	1
Deussen, A; Martin, M	1
Collawn, JF; Dell'Italia, LJ; Ferrario, CM	1
Cudnoch-Jedrzejewska, A; Czarzasta, K; Szczepanska-Sadowska, E	1
Bamba, T; Fujishima, Y; Fukuda, S; Fukusaki, E; Funahashi, T; Hanayama, R; Izumi, Y; Kita, S; Koyama, Y; Maeda, N; Masuda, S; Nagao, H; Nakamura, Y; Nishizawa, H; Obata, Y; Ranscht, B; Shimada, S; Shimomura, I; Takahashi, M; Takeda, H; Tanaka, Y	1
Katanasaka, Y; Oshima, K; Sano, M; Sano, S; Walsh, K; Wang, Y	1
Chen, JZ; Daugherty, A; Lu, HS; Mohammadmoradi, S; Sawada, H; Wu, CH	1
Lei, D; Ruan, Y; Wei, C; Zhang, L; Zhang, Y; Zhou, Y	1
Armstrong, B; Chen, Y; Han, X; Liu, X; Pi, M; Quarles, LD; Sun, Y; Ye, R	1
Hattori, N; Itcho, K; Kobuke, K; Ohno, H; Oki, K; Yoneda, M	1
Cooper, HA; Eguchi, S; Rizzo, V; Scalia, R	1
Awan, FR; Hussain, M; Khan, HN	1
Baladi, MG; da Silva, MB; de Lima, RS; de Souza, LE; Irigoyen, MC; Lacchini, S; Lima, CT; Silva, JCS	1
Chen, Z; Duan, Q; Gong, L; Liu, Z; Wu, P; Xia, F; Yang, T; Zhao, T; Zheng, Z	1
Beiglböck, H; Fellinger, P; Gessl, A; Kautzky-Willer, A; Krebs, M; Luger, A; Mayr, J; Poglitsch, M; Winhofer, Y; Wolf, P	1
Cheng, B; Cui, T; Fu, XB; Li, SH; Liao, X; Liu, HW; Xiao, J; Xiao, LL	1
Campbell, DJ; Koid, SS	1
Tojo, H; Urata, H	1
Katsuya, T; Koriyama, H; Kyutoku, M; Miyake, T; Morishita, R; Nakagami, F; Nakagami, H; Osako, MK; Rakugi, H; Shimamura, M	1
Manickam, DS; Rosenbaugh, EG; Savalia, KK; Zimmerman, MC	1
Eshraghian, M; Farhangi, MA; Keshavarz, SA; Ostadrahimi, A; Saboor-Yaraghi, AA	1
Jaffe, IZ; McCurley, A; McGraw, A; Pruthi, D	1
Ahmed, SB; Ellis, L; Exner, DV; Hemmelgarn, BR; Mann, MC; Sola, DY; Turin, TC	1
Faulkner, J; Jones, LM; Lucero, AA; Palmer, BR; Stoner, L; Young, JM	1
Amiya, E; Inajima, T; Komuro, I; Kurabayashi, M; Maemura, K; Manabe, I; Morita, H; Nagai, R; Nakao, T; Saito, Y; Watanabe, M	1
Aiello, EA; Cingolani, HE; Ennis, IL; Perez, NG	1
Lee, SH	1
Miura, S; Saku, K	1
Alzamora, R; Ayala, P; Barrientos, V; Chiong, M; Díaz-Araya, G; Escudero, N; García, L; Godoy, I; Hevia, D; Jalil, JE; Lavandero, S; Michea, L; Morales, C; Moya, J; Novoa, U; Ocaranza, MP; Pinto, M	1
Chen, J; Gong, L; Hui, R; Shao, L; Song, W; Wang, Y	1
Most, P; Peppel, K; Sen, A	1
Ahmad, S; Ferrario, CM; Nagata, S; Varagic, J	1
Simpson, W; Steiner, M; Van Lieshout, RJ; Wright, L	1
Clarke, NE; Hooper, NM; Lambert, DW; Lambert, LA; Porter, KE; Turner, AJ	1
Guo, P; Wang, B; Wang, C; Zhang, S; Zhang, X	1
Leung, A; Natarajan, R	1
Adler, GK; Brown, JM; Ferri, C; Hopkins, PN; Underwood, PC; Vaidya, A; Williams, GH	1
Chen, B; Wu, QN; Zhang, JX; Zhang, YP	1
Bányai, E; Boczán, J; Daragó, A; Édes, I; Fagyas, M; Papp, Z; Siket, IM; Tóth, A; Úri, K	1
Etelvino, GM; Peluso, AA; Santos, RA	1
Montezano, AC; Nguyen Dinh Cat, A; Rios, FJ; Touyz, RM	1
Ikeda, K	1
Calò, LA; Davis, PA	1
Chiong, M; Jalil, JE; Lavandero, S; Michea, L; Ocaranza, MP	1
Balakumar, P; Jagadeesh, G	1
Ahmed, SB; Holroyd-Leduc, JM; Ramesh, S; Sola, DY; Turin, TC; Wilton, SB	1
Chu, A; Cortese, R; Gozal, D; Wang, Y	1
Kellici, TF; Mavromoustakos, T; Tzakos, AG	1
Byrne, D; Martino, HS; Mertens-Talcott, SU; Noratto, G; Simbo, S	1
Basu, R; Das, SK; Grant, MB; Hall, DA; Kassiri, Z; Oudit, GY; Patel, VB; Ramprasath, T; Takawale, A	1
Bicer, S; Clark, Y; Devine, RD; Jing, R; McCarthy, DO; Reiser, PJ; Stevens, SC; Velten, M; Wold, LE; Youtz, DJ	1
Kikuchi, E; Kosaka, T; Miyajima, A; Oya, M	1
Bamboye, MA; Brewer, AC; Ghigo, A; Gondim, ANS; Hirsch, E; Lederer, WJ; Martin, D; Perino, A; Prosser, BL; Santos, CX; Shah, AM; Ward, CW; Zhang, M	1
Ago, T; Sadoshima, J	1
Azocar, A; Castro, PF; Chiong, M; Jalil, JE; Lavandero, S; Mendoza-Torres, E; Mondaca-Ruff, D; Ocaranza, MP; Oyarzún, A	1
Bolstad, FA; Ito, S; Kyotani, Y; Nagayama, K; Ozawa, K; Yoshizumi, M; Zhao, J	1
Bali, A; Jaggi, AS	1
Cai, Z; Chu, S; Cui, M; He, B; Hu, L; Shen, L; Sun, Z; Wang, X; Yi, J	1
Iwata, K	1
Gao, L; Li, J; Lv, J; Schmull, S; Wang, Z; Xue, S	1
James, PD; Tan, HK; Wong, F	1
Bortolotto, L; Taddei, S	1
Delgado, GE; Grübler, M; Kleber, ME; Krämer, BK; März, W; Siekmeier, R; Tomaschitz, A	1
Allen, TJ; Chow, BS	1
Çetin, A; Kırça, M; Oğuz, N; Uzuner, F; Yeşilkaya, A	1
Bacca, A; Bernini, G; Bruno, RM; Carrara, D; Duranti, E; Ghiadoni, L; Taddei, S	1
De Mello, WC	1
Daiber, A; Kossmann, S; Münzel, T; Wenzel, P	1
Mueller, PJ	1
Schiffrin, EL	1
Raij, L	2
Diz, DI	1
Schindler, C	1
Qian, C; Roks, AJ; Schoemaker, RG; van Gilst, WH	1
Lastra-González, G; Lastra-Lastra, G; Manrique-Acevedo, C; Restrepo-Erazo, K; Sowers, JR	1
de Cavanagh, EM; Ferder, L; Ferder, M; Inserra, F	1
Aplin, M; Christensen, GL; Hansen, JL	1
Bilici, A; Gumus, M; Irmak, R; Orcun, A; Ozates, M; Oztürk, A; Salepci, T; Seker, M; Sonmez, B; Ustaalioğlu, BB; Uyarel, H; Yaylaci, M	1
Karamova, IM; Krasil'nikova, ES; Nosikov, VV; Tereshchenko, SN; Zateĭshchikov, DA; Zhirov, IV	1
Hayashi, T; Takai, S; Yamashita, C	1
Adams, JM; Bardgett, ME; Stocker, SD	1
Inoue, H; Kizawa, T; Nakamura, Y; Sakurai, S; Takahashi, S; Yamauchi, K	1
Dong, YF; Fukuda, M; Kaneko, T; Kataoka, K; Kim-Mitsuyama, S; Matsuba, S; Nakagata, N; Nakamura, T; Nako, H; Ogawa, H; Tokutomi, Y; Yamamoto, E	1
Kirkman, PM; Little, WC	1
Ram, CV	1
Cherkavskaia, OV; Masenko, VP; Shashkova, NV; Tereshchenko, SN	1
Hansen, PB	1
Alajarín, R; Alvarez-Builla, J; Díez-Marqués, ML; García, G; Griera, M; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Sánchez-Alonso, P; Serrano, I; Vaquero, JJ	1
Cheng, JW; Lu, GC; Ma, XJ; Shen, FM; Su, DF; Zhu, KM	1
Ahmad, M; Alexander, RW; Hilenski, L; Ma, M; Nazarewicz, RR; Patrushev, N; Salazar, G; San Martin, A; Ushio-Fukai, M; Xiong, S	1
Day, RO; Graham, GG; Indraratna, PL; Williams, KM	1
Savvatis, K; Schultheiss, HP; Tschöpe, C; Westermann, D	1
Fox, DA; Kashihara, N; Morita, Y; Sakuta, T; Satoh, M	1
Cohn, JN	2
Middeke, M	1
Bachschmid, MM; Cohen, RA; Ho, YS; Maitland-Toolan, KA; Matsui, R; Xu, S	1
Fukushima, K; Kagota, S; Kunitomo, M; Mori, H; Nakamura, K; Nejime, N; Shinozuka, K; Sugimura, K; Tada, Y; Umetani, K	1
Abu-Taha, M; Cerda-Nicolas, JM; Cortijo, J; Estañ, L; Hermenegildo, C; Issekutz, AC; Morcillo, EJ; Orallo, F; Piqueras, L; Rius, C; Sanz, MJ	1
Silva, PM	1
Kong, SS; Li, DL; Liu, JJ; Sun, L; Wang, YH; Yu, XJ; Zang, WJ; Zhao, M; Zhou, J	1
Brunner, HR; Burnier, M; Nussberger, J; Waeber, B	1
Dasgupta, C; Zhang, L	1
Fukuda, D; Hirata, Y; Sata, M	1
Zimmerman, MC	1
Jin, D; Miyazaki, M; Takai, S	1
Gleaves, L; Hampton, J; Khan, S; Siddiquee, K; Smith, LH; Vaughan, DE; Zadory, D	1
Zimmerman, MC; Zucker, IH	1
Cucchiari, D; Graziani, G; Ponticelli, C	1
Dimarakis, I; Koumallos, N; Nteliopoulos, G; Paschalis, A; Yonan, N	1
Hou, X; Jiang, B; Xu, S; Zhi, H	1
Azhar, M; Barnett, JV; Camenisch, TD; Conway, SJ; Doetschman, T; Granzier, HL; Heimark, RL; Runyan, RB	1
Barrick, CJ; Caron, KM; Dackor, RT; Lenhart, PM; Nagle, E	1
Brazin, JA; Levi, R; Morrey, C; Reid, AC; Silver, RB	1
Ahmed, SB; Exner, DV; Hemmelgarn, BR; Mann, MC; Sola, DY; Turin, TC	1
Adams, GN; Schmaier, AH	1
Sadoshima, J; Zablocki, D	1
Chan, JY; Chan, SH	1
Dikalov, SI; Nazarewicz, RR	1
Patel, KP; Schultz, HD	1
Barrett, PQ; Guagliardo, NA; Hu, C; Rusin, CG; Tan, Z	1
Cooper, ME; Du, XJ; Head, GA; Kiriazis, H; Nguyen-Huu, TP; Pickering, R; Thomas, MC; Tikellis, C; Tsorotes, D	1
Dechend, R; Luft, FC; Müller, DN	1
Fukui, K; Matsubara, H; Yamada, H	1
Burrell, LM; Harrap, SB; Patel, SK; Velkoska, E	1
Mehta, AA; Patel, BM	1
Han, CJ; Li, M; Liu, JT; Mao, JJ; Pang, XM	1
Briet, M; Schiffrin, EL	1
Ohishi, M; Rakugi, H; Yamamoto, K	1
Luo, B; Ma, S; Wang, B; Zhang, S; Zhou, J	1
Dell'Italia, LJ; Husain, A	1
Berry, C; Touyz, RM	1
Düsing, R; Schmitz, U; Vetter, H	1
Doggrell, SA	1
Gaede, P; Jensen, GV; Larsen, N; Parving, HH; Pedersen, O; Vedel, P	1
Weber, MA	2
de Boer, RA; Gans, RO; Gansevoort, RT; van Veldhuisen, DJ	1
Abramenko, TV; Garats, IE; Kondakova, NM; Kost, OA; Miagkova, MA; Nikol'skaia, II; Pogozheva, AV	1
Berl, T; Drury, PL; Esmatjes, E; Goldhaber, SZ; Hricik, D; Hunsicker, LG; Lewis, EJ; Lewis, JB; Locatelli, F; Parikh, CR; Pfeffer, MA; Porush, JG; Raz, I; Rouleau, JL; Vanhille, P; Wiegmann, TB; Wolfe, BM	1
Backx, PH; Crackower, MA; Oudit, GY; Penninger, JM	1
Bernardino, JI; Bueso, TS; Jiménez, RT; López, MA; Puig, JG	1
Ball, SG; White, WB	1
Unger, T	3
Cai, H; Griendling, KK; Harrison, DG; Landmesser, U	1
Kumar, A; McFarlane, SI; Sowers, JR	1
Sweitzer, NK	1
Ando, K	2
Gaede, PH; Jensen, GV; Jepsen, PV; Larsen, JN; Parving, HH; Pedersen, OB	1
Díez, J; Fortuño, A; Frühbeck, G; Gómez-Ambrosi, J; Rodríguez, A	1
Goldschmidt-Clermont, PJ; Gregg, D; Rauscher, FM	1
Cai, H; Griendling, KK; Harrison, DG	1
Krantz, MJ	1
Adler, GK; Jonasson, L; Martinez-Vasquez, D; Mukasa, K; Oestreicher, EM; Roubsanthisuk, W; Stone, JR	1
Stanton, A	1
Bramlage, P; Dikow, R; Kirch, W; Lehnert, H; Pittrow, D; Ritz, E; Wittchen, HU	1
Frohlich, ED; Sowers, JR	1
Wenzel, UO; Wolf, G	1
MacDonald, TM; Struthers, AD	1
Granger, DN; Petnehazy, T; Vowinkel, T	1
Hannan, RE; Widdop, RE	1
Ruggenenti, P	1
Ferro, A; Hurairah, H	1
Black, HR	1
Duprez, DA	1
Miyamori, I	1
Urata, H	3
Castro-Chaves, P; Leite-Moreira, AF	1
Raij, L; Schulman, IH; Zhou, MS	1
Volpe, M	1
Touyz, RM	1
Bertrand, ME	1
Harada, E; Ito, T; Mizuno, Y; Yasue, H	1
Remuzzi, G; Ruggenenti, P	1
Campo, C; Ruilope, LM; Segura, J	1
Knuepfer, MM; Lomax, LL; Rowe, KD; Schwartz, JA	1
Burnier, M; Maillard, M; Meier, P	1
Mancini, GB	1
Fiebeler, A; Luft, FC	1
Eguchi, S; Frank, GD; Inagami, T; Kim-Mitsuyama, S; Mifune, M; Motley, ED; Nakashima, H; Ohtsu, H; Rothstein, JD; Saito, S; Sasaki, T; Suzuki, H; Takuwa, Y; Woolfolk, EA	1
Kumar, AH; Ramarao, P	1
Blanco-Colio, LM; Egido, J; Martín-Ventura, JL; Muñoz-García, B; Ruiz-Ortega, M	1
Boner, G; Brenner, BM; Cooper, ME; Crow, RS; de Zeeuw, D; Dickson, T; Kowey, PR; McCarroll, K; Parving, HH; Shahinfar, S	1
Catt, KJ; Hunyady, L	1
Dagenais, NJ; Jamali, F	1
Hussain, MB; Mayr, M; Püntmann, VO; Singer, DR; Xu, Q	1
Re, RN	1
Gelosa, P; Gianella, A; Nobili, E; Sironi, L; Tremoli, E	1
Howes, LG	1
de Champlain, J; Laplante, MA; Wu, R	1
Chao, JY; Eguchi, S; Frank, GD; Nakashima, H; Ohtsu, H; Suzuki, H; Utsunomiya, H	1
Horiuchi, M; Iwai, M; Mogi, M	1
Ferrario, CM; Strawn, WB	1
de Champlain, J; Laplante, MA	1
Hussain, MB; Khong, T; Mayr, M; Püntmann, VO; Singer, DR	1
Griendling, KK; Mehta, PK	1
Itoh, T; Kajikuri, J; Kusama, N; Watanabe, Y	1
Horiuchi, M; Iwai, M	1
Nickenig, G; Ostergren, J; Struijker-Boudier, H	1
Evans, JJ; Nicholls, MG; Pearson, LJ; Rait, C; Yandle, TG	1
Ferrario, CM	1
Fujita, T	1
Fujii, S; Itoh, H; Kawamura, M; Makino, H; Miyamoto, Y; Mogami, H; Sagawa, N; Suga, S; Yoshimasa, Y; Yura, S	1
Egido, J; Esteban, V; Ruiz-Ortega, M	1
Al-Saadi, N; Dechend, R; Feldt, S; Fiebeler, A; Fischer, R; Gapeljuk, A; Gratze, P; Haller, H; Luft, FC; Madwed, JB; Meiners, S; Muller, DN; Park, JK; Schirdewan, A; Shagdarsuren, E; Wellner, M	1
Szczepańska-Sadowska, E	1
Batenburg, WW; Danilov, SM; Danser, AH; van den Meiracker, AH	1
Bukowska, A; Goette, A; Lendeckel, U	1
Buczko, W; Kramkowski, K; Mogielnicki, A	1
Ageno, W; Dentali, F; Romualdi, E	1
Eguchi, S; Frank, GD; Higuchi, S; Ohtsu, H; Shirai, H; Suzuki, H	1
Hirata, Y; Yoshimoto, T	1
Goralski, KB; Sinal, CJ	1
Hitomi, H; Kiyomoto, H; Nishiyama, A	1
Cooper, SA; Habibi, J; Lastra, G; Manrique, C; Sowers, JR; Stas, S; Wei, Y; Whaley-Connell, A	1
Petkow-Dimitrow, P	1
Daemen, MJ; Heeneman, S; Sluimer, JC	1
Blanco-Colio, LM; Egido, J; Martín-Ventura, JL; Tarín, N; Tuñón, J	1
Victor, RG	1
Antonello, M; Bolognesi, M; Di Pascoli, M; Garbisa, S; Giuliani, L; Grego, F; Montemurro, D; Piva, A; Rossi, GP; Sticchi, D	1
Li, XC; Zhuo, JL	1
Cui, LQ; Guo, YJ; Li, WH; Wu, R; Xie, Q	1
Liu, Z	1
Mitsuyama, K	1
Barton, M; Damjanovic, M	1
Miyazaki, T	1
Abel, ED; Buchanan, J; Cooksey, RC; Tabbi-Anneni, I	1
Atlas, SA; Case, DB	1
Biryńczyk, J; Kostka-Wach, M; Lehmann, Z; Stasiński, T; Warenik-Szymankiewicz, A	1
Roberts, JM	1
Husain, A; Liao, Y	1
Broughton Pipkin, F; Lal, S; Sharif, J	1
Almeida, M; Giachelli, CM; Liaw, L; Murry, CE; Schwartz, SM	1
Cockcroft, JR; O'Kane, KP; Webb, DJ	1
Pessina, AC; Rossi, G	1
Brown, L; Sernia, C	1
Squire, IB	1
Oliver, JA	1
Piano, MR	1
Kim, S; Yammamoto, K	1
Dzau, VJ	2
Ganten, D; Urata, H	1
Eberhardt, RT; Frishman, WH; Kang, PM; Kevak, RM	1
Bühler, FR; Holzgreve, H; Laragh, JH	1
Eber, B; Gasser, R; Klein, W; Köppel, H	1
Fyhrquist, F; Metsärinne, K; Tikkanen, I	1
Ganten, D; Nishimura, H; Urata, H	1
Alexander, RW; Griendling, KK; Lassègue, B	1
Fleck, E; Holzmeister, J; Neuss, M; Regitz-Zagrosek, V; Warnecke, C	1
Arakawa, K; Ganten, D; Nishimura, H; Urata, H	1
Krasnikova, TL	1
Brunner, HR; Morgan, T	1
Heistad, DD; Oskarsson, HJ	1
Cody, RJ	1
Baldoncini, R; Bellini, C; De Angelis, C; Desideri, G; Ferri, C; Santucci, A	1
Lavie, CJ; Malik, FS; Mehra, MR; Milani, RV; Re, RN	1
Harrison, DG	1
Gibbons, GH	2
Atlas, SA; Rosendorff, C	1
Lüscher, TF; Noll, G; Ruschitzka, FT	1
Daemen, MJ; Passier, RC; Smits, JF	1
Agarwal, M; Nicholls, MG; Richards, AM	1
Miagkova, MA; Pogozheva, AV; Rozanova, IA; Savitskaia, IuA	1
Aoki, M; Hayashi, SI; Higaki, J; Kida, I; Matsumoto, K; Moriguchi, A; Morishita, R; Nakamura, T; Nakamura, Y; Nakano, N; Ogihara, T	1
Daemen, MJ; de Leeuw, PW; Geraedts, JP; Kroon, AA; Spiering, W; Vreugdenhil, HA	1
Julius, S; Mann, J	1
Okunishi, H	1
Bauters, C; Bertrand, ME; Van Belle, E	1
Stroth, U; Unger, T	1
McInnes, GT	1
Fukami, H; Miyazaki, M; Okunishi, H	1
Gavras, H	3
Shusterman, NH	1
Diz, DI; Ferrario, CM; Tallant, EA	1
Ibsen, H; Rasmussen, S	1
Masana Marín, L; Valero Capilla, FA	1
Leary, AC; MacDonald, TM	1
Bauer, JA; Holycross, BJ; Wattanapitayakul, SK; Weinstein, DM	1
Linz, W; Malinski, T; Schölkens, BA; Wiemer, G; Wohlfart, P	1
Iwao, H; Kim, S	1
De Paolis, P; Volpe, M	1
Buikema, H; Crijns, HJ; Ebels, T; Haber, HE; Kingma, JH; Morshuis, WJ; Oosterga, M; Pinto, YM; van Gilst, WH; Voors, AA	1
Jarvis, B; Markham, A; Spencer, CM	1
Fukamizu, A	1
Giles, TD	1
Henrich, WL; Weir, MR	1
Schrier, RW	1
Antus, B; Mucsi, I; Rosivall, L	1
Berk, BC; Haendeler, J	1
Grassi, G; Mancia, G	1
Luft, FC	2
Horiuchi, M	1
Katovich, MJ; Pachori, A	1
Berry, C; Brosnan, MJ; Dominiczak, AF; Fennell, J; Hamilton, CA	1
Bieringer, M; Breu, V; Dechend, R; Fiebeler, A; Haller, H; Luft, FC; Müller, DN; Park, JK; Schmidt, F; Shagdarsuren, E	1
Madamanchi, N; Patterson, C; Runge, MS; Stouffer, GA	1
Ramahi, TM	1
Arakawa, K	1
Brunner, HR	1
Williams, B	1
Matsubara, H	1
Bandinelli, B; Bertolozzi, I; Boddi, M; Cecioni, I; Coppo, M; Maccherini, M; Modesti, PA; Papa, ML; Polidori, G; Serneri, GG; Toscano, T; Vanni, S	1
Benedict, CR; Katagiri, T; Pakala, R; Watanabe, T	1
Epstein, M	1
Bieringer, M; Dechend, R; Dietz, R; Fiebeler, A; Gulba, D; Haller, H; Luft, FC; Mervaala, E; Muller, DN; Park, JK; Theuer, J	1
Brenner, BM; Cooper, ME; de Zeeuw, D; Keane, WF; Mitch, WE; Parving, HH; Remuzzi, G; Shahinfar, S; Snapinn, SM; Zhang, Z	1
Andersen, S; Arner, P; Brøchner-Mortensen, J; Gomis, R; Lehnert, H; Parving, HH	1
Aumont, MC; Juliard, JM	1
Dart, A; Esler, MD; Fullerton, M; Jennings, G; Komesaroff, PA; Sudhir, K	1
Burnier, M	1
Ando, K; Fujita, T; Ishibashi, K; Kangawa, K; Kato, S; Kitamura, K; Shibagaki, Y; Shimosawa, T	1
Benessiano, J; Henrion, D; Iglarz, M; Levy, BI; Philip, I	1
Abbas, A; Brown, NJ; Byrne, D; Schoenhard, JA; Vaughan, DE	1
Agabiti-Rosei, E; Bova, S; Neri, G; Nussdorfer, GG; Pessina, AC; Rizzoni, D; Rossi, GP; Sacchetto, A	1
Gavras, H; Gavras, I	1
Cheung, BM	1
Jackson, G	1
Hollander, W	1
Abe, H	1
Vertes, V	1
Ball, SG	1
Brilla, CG; Campbell, SE; Reddy, HK; Weber, KT	1
Bühler, FR	1
Greminger, P; Vetter, W	1
Morandini, G; Spanedda, L; Spanedda, M	1
Kukes, VG; Men'shikov, VV; Petrunina, LA	1
Lowenthal, DT	1
Hapke, HJ	1

Reviews

225 review(s) available for angiotensin ii and Cardiovascular Diseases

Article	Year
Role of Serum Amyloid A in Abdominal Aortic Aneurysm and Related Cardiovascular Diseases. Biomolecules, 2021, 12-15, Volume: 11, Issue:12 Topics: Angiotensin II; Aortic Aneurysm, Abdominal; Biomarkers; Cardiovascular Diseases; Gene Expression Regulation; Humans; Serum Amyloid A Protein	2021
Current Trends and Applications of Food-derived Antihypertensive Peptides for the Management of Cardiovascular Disease. Protein and peptide letters, 2022, Volume: 29, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular Diseases; Hypertension; Meat; Nitric Oxide; Peptides	2022
Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting. Pharmacological reviews, 2022, Volume: 74, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Cardiovascular Diseases; Drug Delivery Systems; Female; Humans; Kidney; Male; Renin; Renin-Angiotensin System; Sodium-Glucose Transporter 2 Inhibitors	2022
Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update. Molecules (Basel, Switzerland), 2023, Feb-01, Volume: 28, Issue:3 Topics: Angiotensin II; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucagon-Like Peptide-1 Receptor; Heart Failure; Humans; Hypertension; Hypoglycemic Agents; Liraglutide	2023
Prognostic value of elevated plasma angiotensin-converting enzyme 2 in cardiometabolic diseases: A review. Medicine, 2023, Mar-10, Volume: 102, Issue:10 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Cardiovascular Diseases; Cohort Studies; Humans; Peptidyl-Dipeptidase A; Prognosis; Renin-Angiotensin System	2023
Metabolic Syndrome and Cardiac Remodeling Due to Mitochondrial Oxidative Stress Involving Gliflozins and Sirtuins. Current hypertension reports, 2023, Volume: 25, Issue:6 Topics: Angiotensin II; Cardiovascular Diseases; Diabetes Mellitus; Fibrosis; Humans; Hypertension; Metabolic Syndrome; Oxidative Stress; Sirtuins; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Remodeling	2023
The role of EGFR in vascular AT1R signaling: From cellular mechanisms to systemic relevance. Biochemical pharmacology, 2023, Volume: 217 Topics: Angiotensin II; Cardiovascular Diseases; ErbB Receptors; Humans; Inflammation; Receptor, Angiotensin, Type 1; Tyrosine	2023
Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. The European respiratory journal, 2020, Volume: 56, Issue:1 Topics: Acute Lung Injury; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia; Pneumonia, Viral; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; SARS-CoV-2	2020
Angiotensin II, Hypercholesterolemia, and Vascular Smooth Muscle Cells: A Perfect Trio for Vascular Pathology. International journal of molecular sciences, 2020, Jun-25, Volume: 21, Issue:12 Topics: Angiotensin II; Animals; Antihypertensive Agents; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Cells, Cultured; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Signal Transduction	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Targeting Molecular Mechanism of Vascular Smooth Muscle Senescence Induced by Angiotensin II, A Potential Therapy via Senolytics and Senomorphics. International journal of molecular sciences, 2020, Sep-09, Volume: 21, Issue:18 Topics: Aging; Angiotensin II; Animals; Cardiovascular Diseases; Cellular Senescence; Humans; Molecular Targeted Therapy; Myocytes, Smooth Muscle; Renin-Angiotensin System	2020
The Angiotensin-(1-12)/Chymase axis as an alternate component of the tissue renin angiotensin system. Molecular and cellular endocrinology, 2021, 06-01, Volume: 529 Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Biocatalysis; Bone Marrow; Brain; Cardiovascular Diseases; Chymases; Gene Expression; Humans; Intestines; Kidney; Myocardium; Peptide Fragments; Rats; Renin-Angiotensin System	2021
Contribution of ADAM17 and related ADAMs in cardiovascular diseases. Cellular and molecular life sciences : CMLS, 2021, Volume: 78, Issue:9 Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Animals; Aortic Aneurysm; Cardiovascular Diseases; Cytokines; Humans; Hypertension; Signal Transduction	2021
Novel Targets for Hypertension Drug Discovery. Current hypertension reports, 2021, 03-30, Volume: 23, Issue:4 Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Chemokines; Drug Discovery; Humans; Hypertension	2021
DNA Methylation of the Angiotensinogen Gene, International journal of molecular sciences, 2021, Apr-27, Volume: 22, Issue:9 Topics: Aldosterone; Angiotensin II; Angiotensinogen; Cardiovascular Diseases; CCAAT-Enhancer-Binding Proteins; Cytochrome P-450 CYP11B2; DNA Methylation; Epigenesis, Genetic; Gene Expression; Gene Expression Regulation; Humans; Hypertension; Promoter Regions, Genetic; Transcription Factors	2021
Design of therapeutic vaccines as a novel antibody therapy for cardiovascular diseases. Journal of cardiology, 2017, Volume: 70, Issue:3 Topics: Angiotensin II; Animals; Antibodies; Autoantigens; Cardiovascular Diseases; Humans; Vaccines	2017
Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease. Pharmacological research, 2017, Volume: 125, Issue:Pt A Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Humans; Renin; Renin-Angiotensin System	2017
Effects of natural peptides from food proteins on angiotensin converting enzyme activity and hypertension. Critical reviews in food science and nutrition, 2019, Volume: 59, Issue:8 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Cardiovascular System; Food; Food Analysis; Humans; Hypertension; Peptides; Peptidyl-Dipeptidase A; Renin-Angiotensin System	2019
Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling. Circulation research, 2018, 01-19, Volume: 122, Issue:2 Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiovascular Diseases; Chronic Disease; Chymases; Enzyme Inhibitors; Humans; Mast Cells; Renin-Angiotensin System; Vascular Remodeling	2018
Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders. Current hypertension reports, 2018, 03-19, Volume: 20, Issue:3 Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Cardiovascular Diseases; Humans; Receptors, Vasopressin; Renin-Angiotensin System; Water-Electrolyte Balance	2018
Renin-Angiotensin System and Cardiovascular Functions. Arteriosclerosis, thrombosis, and vascular biology, 2018, Volume: 38, Issue:7 Topics: Angiotensin II; Angiotensinogen; Animals; Cardiovascular Diseases; Cardiovascular System; Hemodynamics; Humans; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Signal Transduction; Ventricular Function	2018
Chymase inhibition and cardiovascular protection. Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:2 Topics: Angiotensin II; Animals; Cardiotonic Agents; Cardiovascular Diseases; Chymases; Humans; Serine Proteases	2013
Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases. American journal of physiology. Regulatory, integrative and comparative physiology, 2013, Jun-01, Volume: 304, Issue:11 Topics: Angiotensin II; Animals; Antioxidants; Cardiovascular Diseases; Diet; Genetic Therapy; Humans; Nanoparticles; Reactive Oxygen Species; Renin-Angiotensin System	2013
Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease. Pflugers Archiv : European journal of physiology, 2013, Volume: 465, Issue:12 Topics: Aging; Aldosterone; Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Carotid Arteries; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Mice; Muscle, Smooth, Vascular; Placenta Growth Factor; Pregnancy Proteins; Receptors, Mineralocorticoid; Signal Transduction	2013
Inflammatory biomarkers for predicting cardiovascular disease. Clinical biochemistry, 2013, Volume: 46, Issue:15 Topics: Angiotensin II; Antioxidants; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cell Adhesion Molecules; Cytokines; Glycation End Products, Advanced; Humans; Inflammation; Oxidative Stress; Prognosis; Risk Factors	2013
The autocrine/paracrine loop after myocardial stretch: mineralocorticoid receptor activation. Current cardiology reviews, 2013, Volume: 9, Issue:3 Topics: Angiotensin II; Autocrine Communication; Calcium; Cardiomegaly; Cardiovascular Diseases; Heart Failure; Humans; Myocardial Contraction; Myocardium; Paracrine Communication; Reactive Oxygen Species; Receptors, Mineralocorticoid; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Thyroid Hormones	2013
[Oxidative stress-mediated chemical modifications to biomacromolecules: mechanism and implication of modifications to human skin keratins and angiotensin II]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2013, Volume: 133, Issue:10 Topics: Aldehydes; Angiotensin II; Animals; Aspartic Acid; Cardiovascular Diseases; DNA; DNA Damage; Glutamyl Aminopeptidase; Humans; Keratins; Lipid Peroxides; Mass Spectrometry; Methionine; Oxidative Stress; Reactive Oxygen Species; Receptor, Angiotensin, Type 2; Skin	2013
Recent progress in the treatment of cardiovascular disease using olmesartan. Clinical and experimental hypertension (New York, N.Y. : 1993), 2014, Volume: 36, Issue:7 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Coronary Stenosis; Disease Models, Animal; Humans; Hypertension; Imidazoles; Plaque, Atherosclerotic; Tetrazoles	2014
ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury. Current hypertension reports, 2014, Volume: 16, Issue:3 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Heart Diseases; Humans; Hypertension; Kidney Diseases; Peptide Fragments; Peptidyl-Dipeptidase A	2014
Depression and cardiovascular disease in women: is there a common immunological basis? A theoretical synthesis. Therapeutic advances in cardiovascular disease, 2014, Volume: 8, Issue:2 Topics: Angiotensin II; Cardiovascular Diseases; Cytokines; Depression; Female; Humans; Hypothalamo-Hypophyseal System; Inflammation; Male; Pituitary-Adrenal System; Pre-Eclampsia; Pregnancy; Serotonin; Sex Factors; T-Lymphocytes, Regulatory	2014
Noncoding RNAs in vascular disease. Current opinion in cardiology, 2014, Volume: 29, Issue:3 Topics: Angiotensin II; Cardiovascular Diseases; Cell Physiological Phenomena; Gene Expression; Humans; Myocytes, Cardiac; RNA Processing, Post-Transcriptional; RNA, Long Noncoding	2014
New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D. Current hypertension reports, 2014, Volume: 16, Issue:6 Topics: Angiotensin I; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Humans; Hypertension; Oligopeptides; Peptide Fragments; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Risk Assessment; Sensitivity and Specificity	2014
Angiotensin II and vascular injury. Current hypertension reports, 2014, Volume: 16, Issue:6 Topics: Angiotensin II; Animals; Atherosclerosis; Cardiovascular Diseases; Humans; Hypertension; Muscle, Smooth, Vascular; Oxidation-Reduction; Reactive Oxygen Species; Renin-Angiotensin System; Signal Transduction; Vascular Remodeling; Vascular System Injuries	2014
[Renin-aldosterone and bone metabolism]. Clinical calcium, 2014, Volume: 24, Issue:6 Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Animals; Bone and Bones; Calcium; Cardiovascular Diseases; Drug Discovery; Humans; Hypertension; Inflammation; Molecular Targeted Therapy; Osteoporosis; Oxidative Stress; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Mineralocorticoid; Renin; Renin-Angiotensin System	2014
A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology. Cellular signalling, 2014, Volume: 26, Issue:10 Topics: Angiotensin II; Arrestins; beta-Arrestins; Cardiovascular Diseases; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction; STAT Transcription Factors	2014
Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptors. Molecules (Basel, Switzerland), 2015, Mar-02, Volume: 20, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiovascular Diseases; Drug Design; Humans; Quantitative Structure-Activity Relationship; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2015
Renin-angiotensin system blockade: Its contribution and controversy. International journal of urology : official journal of the Japanese Urological Association, 2015, Volume: 22, Issue:8 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Humans; Kidney; Nephritis; Renin-Angiotensin System	2015
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension. Therapeutic advances in cardiovascular disease, 2015, Volume: 9, Issue:4 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Kidney Diseases; Mice; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Rats; Renin-Angiotensin System	2015
Angiotensin II-triggered kinase signaling cascade in the central nervous system. Reviews in the neurosciences, 2016, 04-01, Volume: 27, Issue:3 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Central Nervous System; Humans; Protein-Tyrosine Kinases; Renin-Angiotensin System; Signal Transduction	2016
Angiotensins and Their Receptors in Cardiac and Vascular Injury. Current hypertension reviews, 2016, Volume: 12, Issue:3 Topics: Angiotensin II; Angiotensinogen; Angiotensins; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Humans; Hypertension; Renin-Angiotensin System	2016
Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016, Volume: 16, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cardiovascular Diseases; Endothelium, Vascular; Humans; Renin-Angiotensin System; Risk Factors; Vasodilation	2016
Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease. Clinical science (London, England : 1979), 2016, 08-01, Volume: 130, Issue:15 Topics: Angiotensin II; Animals; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Humans; Kidney; Kidney Diseases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction	2016
Local Renin Angiotensin Aldosterone Systems and Cardiovascular Diseases. The Medical clinics of North America, 2017, Volume: 101, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Cardiovascular Diseases; Cell Communication; Epigenesis, Genetic; Humans; Kidney; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System	2017
Redox regulation of cardiovascular inflammation - Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species. Free radical biology & medicine, 2017, Volume: 109 Topics: Angiotensin II; Cardiovascular Diseases; Cardiovascular System; Endothelial Cells; Extracellular Traps; Gene Expression Regulation; Humans; Inflammation; Mitochondria; NADPH Oxidases; Neutrophils; Oxidation-Reduction; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species; Signal Transduction	2017
Nitric oxide and cardiovascular and renal effects. Osteoarthritis and cartilage, 2008, Volume: 16 Suppl 2 Topics: Angiotensin II; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Endothelium, Vascular; Humans; Kidney; Nitric Oxide; Nitric Oxide Donors	2008
The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function. Clinical science (London, England : 1979), 2009, Volume: 116, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Cardiovascular System; Hematopoietic Stem Cells; Humans; Receptors, Angiotensin; Renin-Angiotensin System	2009
Role of aldosterone and angiotensin II in insulin resistance: an update. Clinical endocrinology, 2009, Volume: 71, Issue:1 Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Humans; Insulin Resistance; Metabolic Diseases; Renin-Angiotensin System	2009
Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:3 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Cytoskeleton; Energy Metabolism; Extracellular Matrix; Focal Adhesions; Humans; Integrins; Mitochondria; Mitochondrial Size; Receptor, Angiotensin, Type 1; Signal Transduction; Transforming Growth Factor beta1	2009
Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptor. Trends in cardiovascular medicine, 2008, Volume: 18, Issue:8 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cardiomegaly; Cardiovascular Diseases; Feasibility Studies; GTP-Binding Proteins; Humans; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction	2008
[Polymorphism of ACE, angiotensin II, NO-synthase, estrogen receptor genes and gender differences in their effects on development of cardiovascular pathology]. Kardiologiia, 2009, Volume: 49, Issue:4 Topics: Angiotensin II; Cardiovascular Diseases; DNA; Female; Humans; Male; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Prevalence; Receptors, Estrogen; Risk Factors; Russia; Sex Factors	2009
Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus. Current vascular pharmacology, 2010, Volume: 8, Issue:2 Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Chymases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Oxidative Stress; Renin-Angiotensin System	2010
Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease. Future cardiology, 2009, Volume: 5, Issue:5 Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Drug Therapy, Combination; Fumarates; Humans; Hypertension; Renin; Renin-Angiotensin System	2009
[Apelin--a new protein-regulator in the cardiovascular system]. Terapevticheskii arkhiv, 2009, Volume: 81, Issue:9 Topics: Angiotensin II; Animals; Apelin; Apelin Receptors; Cardiovascular Diseases; Cardiovascular System; Humans; Intercellular Signaling Peptides and Proteins; Receptors, G-Protein-Coupled	2009
A systematic review of angiotensin receptor blockers in preventing stroke. Stroke, 2009, Volume: 40, Issue:12 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiovascular Diseases; Humans; Hypertension; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Risk Factors; Stroke; Treatment Outcome	2009
Rational of the use of aliskiren in hypertension and beyond. Minerva cardioangiologica, 2009, Volume: 57, Issue:6 Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Europe; Fumarates; Germany; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Japan; Prevalence; Prorenin Receptor; Protein Precursors; Randomized Controlled Trials as Topic; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Risk Factors; Tetrazoles; Time Factors; World Health Organization	2009
[Hypertensiology 2010]. Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:25-26 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Dementia; Drug Resistance; Humans; Hypertension; Hypertension, Renal; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Reference Values; Vaccines	2010
From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2010, Volume: 29, Issue:5 Topics: Angiotensin II; Apoptosis; Blood Coagulation; Cardiovascular Diseases; Fibrinolysis; Humans; Muscle, Smooth, Vascular; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction	2010
Experience with angiotensin II antagonists in hypertensive patients. Clinical and experimental pharmacology & physiology, 1996, Volume: 23 Suppl 3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Hypertension; Renin-Angiotensin System	1996
Angiotensin II receptors and drug discovery in cardiovascular disease. Drug discovery today, 2011, Volume: 16, Issue:1-2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiovascular Agents; Cardiovascular Diseases; Drug Discovery; Female; Humans; Pregnancy; Receptors, Angiotensin	2011
[Critical role of renin-angiotensin system in the pathogenesis of atherosclerosis]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Endothelium, Vascular; Humans; Inflammation; Reactive Oxygen Species; Renin-Angiotensin System	2011
Angiotensin II and angiotensin-1-7 redox signaling in the central nervous system. Current opinion in pharmacology, 2011, Volume: 11, Issue:2 Topics: Angiotensin I; Angiotensin II; Animals; Brain; Cardiovascular Diseases; Humans; Neurons; Nitric Oxide; Oxidation-Reduction; Peptide Fragments; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase	2011
Targets of chymase inhibitors. Expert opinion on therapeutic targets, 2011, Volume: 15, Issue:4 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Chymases; Digestive System Diseases; Enzyme Inhibitors; Fibrosis; Humans; Intestinal Diseases; Matrix Metalloproteinase 9; Molecular Targeted Therapy; Transforming Growth Factor beta	2011
The renin-angiotensin system in 2011: new avenues for translational research. Current opinion in pharmacology, 2011, Volume: 11, Issue:2 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Humans; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Translational Research, Biomedical	2011
Hypertension in kidney transplant recipients. Transplant international : official journal of the European Society for Organ Transplantation, 2011, Volume: 24, Issue:6 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Calcium Channel Blockers; Cardiovascular Diseases; Cyclosporine; Diuretics; Glucocorticoids; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Life Style; Renal Artery Obstruction; Vascular Resistance	2011
Therapeutic interventions to renin-angiotensin-aldosterone system, and vascular redox state. Recent patents on cardiovascular drug discovery, 2011, Volume: 6, Issue:2 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Humans; Kidney Diseases; NADPH Oxidases; Oxidation-Reduction; Oxidative Stress; Patents as Topic; Reactive Oxygen Species; Renin-Angiotensin System	2011
Transforming growth factor beta signaling in adult cardiovascular diseases and repair. Cell and tissue research, 2012, Volume: 347, Issue:1 Topics: Aging; Angiotensin II; Animals; Cardiac Rehabilitation; Cardiovascular Diseases; Epithelial-Mesenchymal Transition; Gene Expression; Genetic Variation; Humans; Mitogen-Activated Protein Kinases; Mutation; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2012
Endothelial dysfunction in adults with obstructive sleep apnea. Advances in cardiology, 2011, Volume: 46 Topics: Adult; Angiotensin II; Apoptosis; Biomarkers; Blood Coagulation Disorders; Cardiovascular Diseases; Continuous Positive Airway Pressure; Endothelin-1; Endothelium, Vascular; Humans; Nitric Oxide; Oxidative Stress; Risk Factors; Sleep Apnea, Obstructive	2011
Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system. Current pharmaceutical design, 2011, Volume: 17, Issue:34 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Drug Discovery; Humans; Mast Cells; Myocardium; Nerve Endings; Peptidyl-Dipeptidase A; Receptors, Histamine H3; Renin; Renin-Angiotensin System	2011
Angiotensin-generated reactive oxygen species in brain and pathogenesis of cardiovascular diseases. Antioxidants & redox signaling, 2013, Oct-01, Volume: 19, Issue:10 Topics: Angiotensin II; Animals; Brain; Cardiovascular Diseases; Humans; Muscle, Smooth, Vascular; Neurons; Oxidative Stress; Reactive Oxygen Species; Signal Transduction	2013
Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease. Antioxidants & redox signaling, 2013, Oct-01, Volume: 19, Issue:10 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Humans; Hydrogen Peroxide; Mitochondria; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase	2013
Angiotensin peptides and nitric oxide in cardiovascular disease. Antioxidants & redox signaling, 2013, Oct-01, Volume: 19, Issue:10 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Cardiovascular Diseases; Heart Failure; Humans; Nitric Oxide; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System	2013
Immune mechanisms in angiotensin II-induced target-organ damage. Annals of medicine, 2012, Volume: 44 Suppl 1 Topics: Adaptive Immunity; Angiotensin II; Animals; Autoimmunity; Blood Vessels; Brain; Cardiovascular Diseases; Complement System Proteins; Humans; Immunity, Innate; Inflammation; Kidney; Lymphocytes; Myocardium; NF-kappa B; Renin; Renin-Angiotensin System	2012
[Pathophysiological role of tissue renin-angiotensin-aldosterone system (RAAS) in human atherosclerosis]. Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70, Issue:9 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atherosclerosis; Cardiovascular Diseases; Humans; Renin-Angiotensin System; Treatment Outcome	2012
The ACE2 gene: its potential as a functional candidate for cardiovascular disease. Clinical science (London, England : 1979), 2013, Volume: 124, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Blood Pressure; Cardiovascular Diseases; Genetic Variation; Haplotypes; Humans; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Sex Factors	2013
Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases. European journal of pharmacology, 2012, Dec-15, Volume: 697, Issue:1-3 Topics: Aldosterone; Angiotensin II; Animals; Autocrine Communication; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus; Humans; Paracrine Communication; Renin-Angiotensin System; Signal Transduction; Water-Electrolyte Balance	2012
Vascular actions of aldosterone. Journal of vascular research, 2013, Volume: 50, Issue:2 Topics: Adipocytes; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Vessels; Cardiovascular Diseases; Endothelin A Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Hypertrophy; Metabolic Syndrome; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Muscle, Smooth, Vascular; Oxidative Stress; Receptor, Endothelin A; Receptors, Mineralocorticoid; Renin-Angiotensin System; Signal Transduction; Sodium; Vasculitis; Vasoconstriction	2013
Angiotensin (1-7) and other angiotensin peptides. Current pharmaceutical design, 2013, Volume: 19, Issue:17 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Glucose; Humans; Kidney Diseases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled	2013
Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases. Current opinion in cardiology, 2002, Volume: 17, Issue:4 Topics: Angiotensin I; Angiotensin II; Arteriosclerosis; Cardiomegaly; Cardiovascular Diseases; Chymases; Heart Diseases; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Serine Endopeptidases	2002
Recent advances in angiotensin II signaling. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2002, Volume: 35, Issue:9 Topics: Angiotensin II; Cardiovascular Diseases; Humans; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Protein-Tyrosine Kinases; Reactive Oxygen Species; Receptor Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction	2002
[Intracellular signal transduction of angiotensin II and possible interventions in the renin-angiotensin system]. Deutsche medizinische Wochenschrift (1946), 2002, Nov-08, Volume: 127, Issue:45 Topics: Angiotensin II; Cardiovascular Diseases; Humans; Mitogen-Activated Protein Kinases; Renin-Angiotensin System; Risk Factors; Signal Transduction	2002
Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease? Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cough; Diabetes Complications; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardial Infarction; Receptor, Angiotensin, Type 1	2002
The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease. Reviews in cardiovascular medicine, 2002,Fall, Volume: 3, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Receptors, Angiotensin	2002
The role of ACE2 in cardiovascular physiology. Trends in cardiovascular medicine, 2003, Volume: 13, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Endothelium, Vascular; Humans; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Renin-Angiotensin System	2003
Clinical profile of eprosartan. Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:6 Topics: Acrylates; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Humans; Imidazoles; Renin-Angiotensin System; Thiophenes; Treatment Outcome	2002
Debate: angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers--a gap in evidence-based medicine. The American journal of cardiology, 2003, May-22, Volume: 91, Issue:10A Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Evidence-Based Medicine; Humans; Hypertension; Risk Factors	2003
The ongoing telmisartan alone and in combination with ramipril global endpoint trial program. The American journal of cardiology, 2003, May-22, Volume: 91, Issue:10A Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Ramipril; Renin-Angiotensin System; Telmisartan	2003
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. The American journal of cardiology, 2003, Jun-19, Volume: 91, Issue:12A Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Diabetes Complications; Diabetes Mellitus; Humans; Insulin Resistance; Kidney Failure, Chronic; Rats	2003
[Oxidative stress]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:7 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Insulin Resistance; Lipid Metabolism; Nitric Oxide; Oxidants; Oxidative Stress; Reactive Oxygen Species	2003
Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. Journal of physiology and biochemistry, 2003, Volume: 59, Issue:1 Topics: Adiponectin; Adipose Tissue; Angiotensin II; Animals; Calcium; Cardiovascular Diseases; Cations, Divalent; Endocrine Glands; Intercellular Signaling Peptides and Proteins; Leptin; Obesity; Potassium Chloride; Proteins; Rats; Rats, Wistar	2003
Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. American journal of physiology. Cell physiology, 2003, Volume: 285, Issue:4 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Cardiovascular System; Humans; NADPH Oxidases; rac GTP-Binding Proteins; Receptor Protein-Tyrosine Kinases; Receptors, Cell Surface; Structure-Activity Relationship; Superoxides	2003
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends in pharmacological sciences, 2003, Volume: 24, Issue:9 Topics: Angiotensin II; Animals; Blood Vessels; Cardiovascular Agents; Cardiovascular Diseases; Enzyme Activation; Humans; Mice; NADPH Oxidases; Reactive Oxygen Species	2003
Therapeutic potential of renin inhibitors in the management of cardiovascular disorders. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2003, Volume: 3, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Humans; Receptors, Angiotensin; Renin; Renin-Angiotensin System	2003
Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. The Medical clinics of North America, 2004, Volume: 88, Issue:1 Topics: Angiotensin II; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin; Insulin Resistance; Obesity; Risk Factors	2004
Angiotensin II and cell cycle regulation. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:4 Topics: Angiotensin II; Animals; Apoptosis; Blood Vessels; Cardiovascular Diseases; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Division; Cell Size; Endothelins; G1 Phase; Heart; Humans; Hypertrophy; Kidney; Kidney Diseases; Myocardium	2004
Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovascular research, 2004, Mar-01, Volume: 61, Issue:4 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Endothelium, Vascular; Eplerenone; Humans; Kidney; Mineralocorticoid Receptor Antagonists; Myocardium; Spironolactone	2004
Modulation of the inflammatory response in cardiovascular disease. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5 Topics: Angiotensin II; Animals; Blood Platelets; Cardiovascular Diseases; CD40 Antigens; CD40 Ligand; Cell Adhesion Molecules; Disease Progression; Endothelium, Vascular; Humans; Inflammation; Integrins; Models, Animal; Oxidative Stress; Renin-Angiotensin System; Risk Factors; Thrombophilia	2004
Vascular angiotensin II actions mediated by angiotensin II type 2 receptors. Current hypertension reports, 2004, Volume: 6, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Cardiovascular Diseases; Cardiovascular System; Humans; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin	2004
Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies. Seminars in nephrology, 2004, Volume: 24, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Chronic Disease; Drug Therapy, Combination; Humans; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Remission Induction	2004
The role of the endothelium in the control of vascular function. International journal of clinical practice, 2004, Volume: 58, Issue:2 Topics: Angiotensin II; Arteriosclerosis; Cardiovascular Diseases; Cell Adhesion Molecules; Coagulants; Diabetes Mellitus; Endothelin-1; Endothelium, Vascular; Female; Humans; Pre-Eclampsia; Pregnancy; Vasoconstrictor Agents; Vasodilator Agents	2004
Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data. American heart journal, 2004, Volume: 147, Issue:4 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Eplerenone; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Renin-Angiotensin System; Spironolactone	2004
[Involvement of Aldosterone and mineralocorticoid receptor in pathogenesis of cardiovascular diseases]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3 Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Angiotensin II; Cardiovascular Diseases; Fibrosis; Humans; Hydrocortisone; Mineralocorticoid Receptor Antagonists; Myocardium; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Spironolactone	2004
[involvement of chymase in pathogenesis of cardiovascular diseases]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Chymases; Humans; Peptidyl-Dipeptidase A; Renin; Serine Endopeptidases	2004
[Renin-angiotensin system and its role in cardiovascular physiopathology and therapy]. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2004, Volume: 23 Suppl 2 Topics: Angiotensin II; Cardiovascular Diseases; Heart Failure; Humans; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction; Time Factors	2004
Nitric oxide, angiotensin II, and hypertension. Seminars in nephrology, 2004, Volume: 24, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Humans; Hypertension; Nitric Oxide; Prognosis; Renal Circulation; Renin-Angiotensin System; Risk Factors	2004
Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2004, Volume: 37, Issue:8 Topics: Angiotensin II; Cardiovascular Diseases; Humans; Muscle, Smooth, Vascular; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Ventricular Remodeling	2004
Provision of cardiovascular protection by ACE inhibitors: a review of recent trials. Current medical research and opinion, 2004, Volume: 20, Issue:10 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Cardiovascular Diseases; Clinical Trials as Topic; Heart Arrest; Humans; Hypertension; Myocardial Infarction; Oxidative Stress; Risk Factors; Vasodilation	2004
[Renin-angiotensin-aldosterone system and natriuretic peptide system--reference to cardiovascular diseases]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9 Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiovascular Diseases; Drug Design; Heart Failure; Humans; Hypertension; Kidney Tubules, Distal; Natriuresis; Natriuretic Peptides; Renin-Angiotensin System; Sodium; Sodium, Dietary; Water-Electrolyte Balance	2004
[Protective effects of antioxidants against cardiovascular damage]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9 Topics: Adrenomedullin; Angiotensin II; Animals; Antioxidants; Cardiovascular Diseases; Cyclic N-Oxides; Humans; Insulin Resistance; Life Style; Lipoproteins, LDL; Nitric Oxide; Oxidative Stress; Peptides; Reactive Oxygen Species; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Spin Labels	2004
Methods of cardio-renal protection in non-diabetic chronic nephropathies. Roczniki Akademii Medycznej w Bialymstoku (1995), 2004, Volume: 49 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Glomerulonephritis; Humans; Kidney Failure, Chronic; Treatment Outcome	2004
Influence of chronic kidney disease development and renin-angiotensin system inhibition on cardiovascular prognosis. Current medicinal chemistry. Cardiovascular and hematological agents, 2005, Volume: 3, Issue:1 Topics: Angiotensin II; Cardiovascular Diseases; Chronic Disease; Creatinine; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney Diseases; Male; Prognosis; Renin-Angiotensin System; Risk Factors	2005
Role of angiotensin II and corticotropin-releasing hormone in hemodynamic responses to cocaine and stress. Regulatory peptides, 2005, Apr-15, Volume: 127, Issue:1-3 Topics: Angiotensin II; Animals; Autonomic Nervous System; Behavior; Cardiovascular Diseases; Cocaine; Corticotropin-Releasing Hormone; Disease Susceptibility; Hemodynamics; Humans; Stress, Physiological; Sympathomimetics; Vasoconstrictor Agents	2005
The future of angiotensin II inhibition in cardiovascular medicine. Current drug targets. Cardiovascular & haematological disorders, 2005, Volume: 5, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Kidney Diseases; Myocardial Infarction; Protease Inhibitors; Renin; Risk Factors	2005
The 'double dip' hypothesis: simultaneous prevention of cardiovascular and pulmonary morbidity and mortality using angiotensin II type 1 receptor blockers. The Canadian journal of cardiology, 2005, May-01, Volume: 21, Issue:6 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Humans; Pulmonary Disease, Chronic Obstructive; Receptor, Angiotensin, Type 1; Risk Factors	2005
The mineralocorticoid receptor and oxidative stress. Heart failure reviews, 2005, Volume: 10, Issue:1 Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Humans; Oxidative Stress; Reactive Oxygen Species; Receptors, Mineralocorticoid	2005
Saga of renin-angiotensin system and calcium channels in hypertensive diabetics: does it have a therapeutic edge? Cardiovascular drug reviews, 2005,Summer, Volume: 23, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Channel Blockers; Calcium Channels; Cardiovascular Diseases; Diabetes Complications; Drug Therapy, Combination; Humans; Hypertension; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2005
[Vasoprotective effects of statins and angiotensin II blockers in atherothrombosis]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2005, Volume: 25 Suppl 2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticholesteremic Agents; Antihypertensive Agents; Arteriosclerosis; Cardiovascular Diseases; Cholesterol; Cyclooxygenase Inhibitors; Endothelium, Vascular; Haplorhini; Humans; Hypertension; Hypolipidemic Agents; Lipid Metabolism; Randomized Controlled Trials as Topic; Renin-Angiotensin System	2005
Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Molecular endocrinology (Baltimore, Md.), 2006, Volume: 20, Issue:5 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Mellitus; Humans; Neoplasms; Receptor, Angiotensin, Type 1; Signal Transduction	2006
Protective effects of angiotensin II interruption: evidence for antiinflammatory actions. Pharmacotherapy, 2005, Volume: 25, Issue:9 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Clinical Trials as Topic; Cytokines; Drug Therapy, Combination; Humans; Inflammation Mediators; T-Lymphocytes, Helper-Inducer	2005
Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease. Nature clinical practice. Cardiovascular medicine, 2004, Volume: 1, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Carboxypeptidases; Cardiovascular Diseases; Diet, Sodium-Restricted; Humans; Intracellular Fluid; Mineralocorticoid Receptor Antagonists; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System	2004
Anti-inflammatory properties of drugs acting on the renin-angiotensin system. Drugs of today (Barcelona, Spain : 1998), 2005, Volume: 41, Issue:9 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Cardiovascular Diseases; Humans; Kidney Diseases; Renin-Angiotensin System	2005
The effects of lipid-lowering drug therapy on cardiovascular responsiveness in type 2 diabetic patients. Diabetes, obesity & metabolism, 2006, Volume: 8, Issue:1 Topics: Angiotensin II; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dyslipidemias; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Intravenous; Lipoproteins; Norepinephrine; Vasodilation	2006
Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature. Current vascular pharmacology, 2006, Volume: 4, Issue:1 Topics: Angiotensin II; Cardiovascular Diseases; Endothelium, Vascular; Humans; Muscle, Smooth, Vascular; Protein Kinases; Receptors, Vascular Endothelial Growth Factor; Signal Transduction	2006
Signaling crosstalk angiotensin II receptor subtypes and insulin. Endocrine journal, 2006, Volume: 53, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucose; Humans; Hypertension; Insulin; Insulin Resistance; Mice; Models, Animal; Rats; Receptor Cross-Talk; Receptors, Angiotensin; Risk Factors; Signal Transduction	2006
Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. The American journal of cardiology, 2006, Jul-01, Volume: 98, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; E-Selectin; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukins; Renin-Angiotensin System; Tumor Necrosis Factor-alpha	2006
The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidase. Canadian journal of physiology and pharmacology, 2006, Volume: 84, Issue:1 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Endothelin-1; Humans; NADPH Oxidases	2006
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. American journal of physiology. Cell physiology, 2007, Volume: 292, Issue:1 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Humans; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction; Structure-Activity Relationship; Vascular Diseases	2007
[Roles of reactive oxygen species in vascular endothelial dysfunction]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 5 Topics: Angiotensin II; Animals; Biological Factors; Cardiovascular Diseases; Endothelium, Vascular; Humans; Mitochondria; NADPH Oxidases; Nitric Oxide Synthase Type III; Reactive Oxygen Species	2006
[Clinical significance of non-ACE-dependent angiotensin II-forming system]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiovascular Diseases; Chymases; Enzyme Inhibitors; Humans; Hypertension; Serine Endopeptidases	2006
[Cell proliferation]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiovascular Diseases; Cardiovascular System; Cell Proliferation; Humans; Receptor, Angiotensin, Type 2; Ventricular Remodeling	2006
Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2006, Volume: 7 Suppl 1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Cardiac Output, Low; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System	2006
Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2006, Volume: 7, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Humans; Mineralocorticoid Receptor Antagonists; Randomized Controlled Trials as Topic; Renin; Renin-Angiotensin System	2006
Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2006, Volume: 7, Issue:3 Topics: Adrenomedullin; Angiotensin II; Cardiovascular Diseases; Humans; Hypertension; Insulin Resistance; Metabolic Syndrome; Renin-Angiotensin System; Sodium Chloride	2006
Pathological involvement of chymase-dependent angiotensin II formation in the development of cardiovascular disease. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:2 Suppl Topics: Angiotensin II; Animals; Cardiovascular Diseases; Chymases; Cricetinae; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Myocardium	2000
The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases. Trends in cardiovascular medicine, 2007, Volume: 17, Issue:1 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Humans; NF-kappa B; Renin-Angiotensin System; Vasculitis	2007
Neuropeptides in neurogenic disorders of the cardiovascular control. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2006, Volume: 57 Suppl 11 Topics: Angiotensin II; Brain; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Cytokines; Heart Failure; Humans; Hypertension; Nerve Net; Neuropeptides; Neurosecretory Systems; Stress, Psychological; Vasopressins	2006
ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition? Pharmacology & therapeutics, 2007, Volume: 113, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Drug Resistance; Genotype; Humans; Isoenzymes; Peptidyl-Dipeptidase A; Phenotype; Polymorphism, Genetic; Predictive Value of Tests; Signal Transduction; Up-Regulation	2007
Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling). Current opinion in pharmacology, 2007, Volume: 7, Issue:2 Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Drug Delivery Systems; Heart Atria; Humans; Inflammation Mediators; Oxidative Stress; Signal Transduction	2007
Are the endothelial mechanisms of ACE-Is already established? Pharmacological reports : PR, 2006, Volume: 58 Suppl Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cardiovascular Diseases; Endothelium, Vascular; Epoprostenol; Humans; Nitric Oxide	2006
Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clinical science (London, England : 1979), 2007, Volume: 112, Issue:8 Topics: Angiotensin II; Cardiovascular Diseases; Endothelium, Vascular; GTP-Binding Proteins; Humans; Muscle, Smooth, Vascular; Receptor, Angiotensin, Type 1; Receptors, Growth Factor; Renin-Angiotensin System; Signal Transduction	2007
Aldosterone as a cardiovascular risk hormone. Endocrine journal, 2007, Volume: 54, Issue:3 Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Epithelial Cells; Humans; Models, Biological; Oxidative Stress; Receptors, Mineralocorticoid; Risk Factors	2007
Type 2 diabetes and cardiovascular disease: getting to the fat of the matter. Canadian journal of physiology and pharmacology, 2007, Volume: 85, Issue:1 Topics: Adiponectin; Adipose Tissue; Angiotensin II; Animals; Cardiovascular Diseases; Complement Activation; Complement C3a; Complement Factor D; Cytokines; Diabetes Mellitus, Type 2; Fibrinolysis; Humans; Inflammation; Insulin Resistance; Interleukin-6; Leptin; Nicotinamide Phosphoribosyltransferase; Obesity; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Resistin; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Risk Factors; Tumor Necrosis Factor-alpha	2007
Angiotensin II and oxidative stress. Current opinion in cardiology, 2007, Volume: 22, Issue:4 Topics: Angiotensin II; Cardiovascular Diseases; Cardiovascular System; Clinical Trials as Topic; Humans; Hypertension; NADP; Oxidative Stress; Reactive Oxygen Species	2007
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Hypertension; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Kidney Diseases; Metabolic Syndrome; Mineralocorticoids; Muscle, Skeletal; Myocardium; Oxidative Stress; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Signal Transduction	2007
[New therapeutic targets for ACE inhibitors and angiotensin receptor blockers]. Polskie Archiwum Medycyny Wewnetrznej, 2007, Volume: 117, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Losartan; Metabolic Syndrome; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Risk Reduction Behavior; Telmisartan; Treatment Outcome	2007
Angiotensin-converting enzyme and vascular remodeling. Circulation research, 2007, Aug-31, Volume: 101, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Cardiovascular Diseases; Endothelium, Vascular; Humans; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Signal Transduction; Tunica Intima	2007
Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors. Vascular health and risk management, 2007, Volume: 3, Issue:4 Topics: Angiotensin II; Cardiovascular Diseases; Humans; Hypercholesterolemia; Hypertension; Risk Factors; Thrombosis	2007
Pathophysiology of target-organ disease: does angiotensin II remain the key? Journal of clinical hypertension (Greenwich, Conn.), 2007, Volume: 9, Issue:11 Suppl 4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Disease Progression; Humans; Hypertension; Losartan; Myocardial Infarction; Renin; Renin-Angiotensin System; Stroke; Tetrazoles; Treatment Outcome; Valine; Valsartan	2007
Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury. Current opinion in nephrology and hypertension, 2008, Volume: 17, Issue:1 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Humans; Kidney Diseases; NF-kappa B; Signal Transduction	2008
[Multiphasic action of AT1 receptor blockers and their therapeutic effects for cardiovascular diseases]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2008, Volume: 131, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Endothelium, Vascular; Humans; Insulin Resistance; MAP Kinase Kinase Kinase 5; Metabolic Syndrome; Oxidative Stress	2008
Fat intake and cardiovascular response. Current hypertension reports, 2008, Volume: 10, Issue:1 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Cardiovascular System; Dietary Fats; Endothelin-1; Humans; Nitric Oxide; Obesity; Reactive Oxygen Species; Renin-Angiotensin System; Risk Factors	2008
[Diversity in mechanism of angiotensin II production and application of the suppressive agents]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2008, Volume: 131, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Chymases; Humans; Peptidyl-Dipeptidase A; Renin	2008
Renin in essential hypertension. Clinics in endocrinology and metabolism, 1981, Volume: 10, Issue:3 Topics: Adrenergic beta-Antagonists; Age Factors; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiovascular Diseases; Humans; Hypertension; Posture; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Saralasin; Sodium	1981
[Effect of oral contraceptives on the circulatory system]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1980, May-12, Volume: 35, Issue:19 Topics: Aldosterone; Angiotensin II; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Coronary Disease; Female; Humans; Hypertension; Renin; Stimulation, Chemical; Thrombosis	1980
Oestrogens and hypertension. Clinics in endocrinology and metabolism, 1981, Volume: 10, Issue:3 Topics: Adolescent; Adult; Age Factors; Angiotensin II; Cardiac Output; Cardiovascular Diseases; Contraceptives, Oral; Estrogens; Female; Humans; Hypertension; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Pituitary-Adrenal System; Progestins; Prospective Studies; Prostaglandins; Renin; Renin-Angiotensin System; Sympathetic Nervous System	1981
The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases. The Canadian journal of cardiology, 1995, Volume: 11 Suppl F Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Chymases; Heart Diseases; Humans; Hypertension; Molecular Biology; Serine Endopeptidases	1995
Tissue angiotensin generation and regulation of vascular tone. Pharmacology & therapeutics, 1995, Volume: 65, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Cardiovascular Diseases; Humans; Hypertension; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Vascular Resistance; Vasoconstriction	1995
[Molecular biology and cardiac and vascular changes in hypertension: focus on the renin-angiotensin system]. Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna, 1994, Volume: 9 Suppl Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Coronary Disease; Female; Genetic Markers; Humans; Hypertension; Hypertension, Renal; Male; Mice; Mice, Inbred DBA; Mice, Transgenic; Middle Aged; Prospective Studies; Rats; Renin-Angiotensin System; Risk Factors	1994
Angiotensin receptors in cardiovascular diseases. Clinical and experimental pharmacology & physiology, 1994, Volume: 21, Issue:10 Topics: Acromegaly; Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Mellitus; Humans; Receptors, Angiotensin; Renin-Angiotensin System; Thyroid Diseases	1994
Actions of angiotensin II on cerebral blood flow autoregulation in health and disease. Journal of hypertension, 1994, Volume: 12, Issue:11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Brain; Cardiovascular Diseases; Cerebrovascular Circulation; Homeostasis; Humans	1994
Cardiovascular disease and hypertension. Current opinion in nephrology and hypertension, 1993, Volume: 2, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Humans; Hypertension	1993
Cellular and signaling mechanisms of cardiac hypertrophy. The Journal of cardiovascular nursing, 1994, Volume: 8, Issue:4 Topics: Adenosine Triphosphate; Angiotensin II; Cardiovascular Diseases; Catecholamines; Gene Expression; Genes, fos; Genes, myc; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Patient Care Planning; Risk Factors; Signal Transduction; Thyroid Hormones	1994
[Pharmacology of the renin-angiotensin system]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1994, Volume: 104, Issue:4 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Cloning, Molecular; Humans; Receptors, Angiotensin; Renin; Renin-Angiotensin System	1994
Cell biology and genetics of angiotensin in cardiovascular disease. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1994, Volume: 12, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Cardiovascular Diseases; Cell Division; Coronary Disease; Humans; Vascular Diseases; Ventricular Function	1994
Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase. European heart journal, 1993, Volume: 14 Suppl I Topics: Angiotensin II; Cardiovascular Diseases; Chymases; Humans; Myocardium; Peptidyl-Dipeptidase A; Serine Endopeptidases	1993
Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy. Journal of clinical pharmacology, 1993, Volume: 33, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cardiovascular Diseases; Heart Failure; Homeostasis; Humans; Hypertension; Imidazoles; Losartan; Receptors, Angiotensin; Renin-Angiotensin System; Saralasin; Tetrazoles	1993
[Recent molecular and pharmacologic aspects of ACE inhibitors]. Wiener medizinische Wochenschrift (1946), 1995, Volume: 145, Issue:23 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Bradykinin; Cardiovascular Diseases; Electrocardiography; Humans; Platelet Aggregation; Sodium-Potassium-Exchanging ATPase	1995
Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. Journal of human hypertension, 1995, Volume: 9 Suppl 5 Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Imidazoles; Losartan; Rats; Renin-Angiotensin System; Tetrazoles	1995
Chymase-dependent angiotensin II forming systems in humans. American journal of hypertension, 1996, Volume: 9, Issue:3 Topics: Angiotensin II; Animals; Blood Vessels; Cardiovascular Diseases; Chymases; Heart; Humans; Myocardium; Peptidyl-Dipeptidase A; Serine Endopeptidases; Vasoconstrictor Agents	1996
Angiotensin receptors and their therapeutic implications. Annual review of pharmacology and toxicology, 1996, Volume: 36 Topics: Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Gene Expression Regulation; Humans; Imidazoles; Losartan; Molecular Sequence Data; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System; Structure-Activity Relationship; Tetrazoles; Tissue Distribution	1996
Molecular biology of angiotensin receptors and their role in human cardiovascular disease. Journal of molecular medicine (Berlin, Germany), 1996, Volume: 74, Issue:5 Topics: Angiotensin I; Angiotensin II; Cardiovascular Diseases; Humans; Receptors, Angiotensin	1996
Angiotensin-converting enzyme-independent pathways of angiotensin II formation in human tissues and cardiovascular diseases. Blood pressure. Supplement, 1996, Volume: 2 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Chymases; Humans; Peptidyl-Dipeptidase A; Serine Endopeptidases; Signal Transduction	1996
[Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy]. Klinicheskaia meditsina, 1996, Volume: 74, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Imidazoles; Kidney Diseases; Losartan; Myocardial Infarction; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Time Factors	1996
The renin-angiotensin system and the heart: beyond 2000. Heart (British Cardiac Society), 1996, Volume: 76, Issue:3 Suppl 3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Heart; Humans; Hypertrophy, Left Ventricular; Kidney; Rats; Renin; Renin-Angiotensin System; Risk Factors; Sodium	1996
The integrated effects of angiotensin II. The American journal of cardiology, 1997, Mar-06, Volume: 79, Issue:5A Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Cardiovascular Diseases; Endothelium, Vascular; Fibrinolysis; Heart Failure; Humans; Renin-Angiotensin System	1997
Renin-angiotensin system: genes to bedside. American heart journal, 1997, Volume: 134, Issue:3 Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Animals; Arteriosclerosis; Blood Pressure; Cardiomyopathy, Dilated; Cardiovascular Diseases; Constriction, Pathologic; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Infarction; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Recurrence; Renin-Angiotensin System	1997
Endothelial function and oxidant stress. Clinical cardiology, 1997, Volume: 20, Issue:11 Suppl 2 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hydrogen Peroxide; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Nitric Oxide; Nitroglycerin; Oxidative Stress; Superoxides	1997
Cardioprotective mechanisms of ACE inhibition. The angiotensin II-nitric oxide balance. Drugs, 1997, Volume: 54 Suppl 5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Cardiovascular Diseases; Coronary Disease; Endothelium, Vascular; Humans; Microcirculation; Myocardium; Nitric Oxide; Reactive Oxygen Species; Vascular Resistance; Vasodilation	1997
The renin-angiotensin system--from Tigerstedt to Goldblatt to ACE inhibition and beyond. The Mount Sinai journal of medicine, New York, 1998, Volume: 65, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; History, 19th Century; History, 20th Century; Humans; Renin-Angiotensin System	1998
Combination of ACE inhibitors and calcium antagonists: a logical approach. Journal of cardiovascular pharmacology, 1998, Volume: 31 Suppl 2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Calcium Channel Blockers; Cardiovascular Diseases; Drug Therapy, Combination; Endothelin-1; Endothelium, Vascular; Humans; Muscle, Smooth, Vascular	1998
Should we aim at tissue renin-angiotensin systems? Pharmacy world & science : PWS, 1998, Volume: 20, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Gene Expression Regulation, Enzymologic; Humans; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptors, Angiotensin; Renin-Angiotensin System	1998
The importance of the renin-angiotensin system in cardiovascular disease. Journal of human hypertension, 1998, Volume: 12, Issue:5 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Diabetic Nephropathies; Heart Failure; Humans; Hypertension; Renin-Angiotensin System; Sensitivity and Specificity	1998
[The relationship between genetic polymorphisms and disease, illustrated by the renin-angiotensin-aldosterone system and cardiovascular disease]. Nederlands tijdschrift voor geneeskunde, 1998, Jun-20, Volume: 142, Issue:25 Topics: Angiotensin II; Angiotensinogen; Cardiovascular Diseases; Chromosome Mapping; Female; Genetic Markers; Humans; Kidney Diseases; Male; Peptidyl-Dipeptidase A; Point Mutation; Polymorphism, Genetic; Receptors, Angiotensin; Renin-Angiotensin System; Spondylitis, Ankylosing	1998
[Angiotensin II formation by chymase in the cardiovascular tissue]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1998, Volume: 112, Issue:3 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Cardiovascular System; Chymases; Cricetinae; Dogs; Haplorhini; Humans; Mice; Rabbits; Rats; Serine Endopeptidases; Species Specificity	1998
[From the angiogenic response to ischemia to the validation of the concept of "therapeutic angiogenesis"]. Archives des maladies du coeur et des vaisseaux, 1998, Volume: 91, Issue:9 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Disease Models, Animal; Endothelial Growth Factors; Humans; Lymphokines; Myocardial Ischemia; Neovascularization, Physiologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1998
The pathophysiology of hypertension: the importance of angiotensin II in cardiovascular remodeling. American journal of hypertension, 1998, Volume: 11, Issue:11 Pt 2 Topics: Angiotensin II; Animals; Arteriosclerosis; Cardiovascular Diseases; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System	1998
The renin-angiotensin system and its receptors. Journal of cardiovascular pharmacology, 1999, Volume: 33 Suppl 1 Topics: Angiotensin II; Animals; Blood Pressure; Cardiovascular Diseases; Cell Division; Humans; Hypertension; Kidney Diseases; Receptors, Angiotensin; Renin-Angiotensin System; Salts; Water	1999
Angiotensin II antagonism in clinical practice: experience with valsartan. Journal of cardiovascular pharmacology, 1999, Volume: 33 Suppl 1 Topics: Age Factors; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Drug Synergism; Humans; Kidney Diseases; Racial Groups; Sex Factors; Tetrazoles; Valine; Valsartan	1999
Chymase: its pathophysiological roles and inhibitors. Current pharmaceutical design, 1998, Volume: 4, Issue:6 Topics: Angiotensin I; Angiotensin II; Animals; Cardiovascular Diseases; Chymases; Cytokines; Humans; Inflammation; Peptidyl-Dipeptidase A; Serine Endopeptidases; Serine Proteinase Inhibitors; Species Specificity; Structure-Activity Relationship	1998
Safety and efficacy of eprosartan, a new angiotensin II receptor blocker. American heart journal, 1999, Volume: 138, Issue:3 Pt 2 Topics: Acrylates; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Drug Interactions; Humans; Hypertension; Imidazoles; Thiophenes	1999
[Angiotensin II receptor antagonists. Clinically significant differences]. Ugeskrift for laeger, 1999, Sep-20, Volume: 161, Issue:38 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Losartan; Receptors, Angiotensin; Renin-Angiotensin System	1999
Neurohormonal modulation in cardiovascular disease. American heart journal, 2000, Volume: 139, Issue:1 Pt 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Humans; Receptors, Angiotensin; Renin-Angiotensin System	2000
Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology. International journal of clinical practice, 1998, Volume: 52, Issue:7 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Cardiovascular System; Heart Failure; Humans; Hypertension; Losartan; Receptors, Angiotensin; Renin-Angiotensin System	1998
Interactions among ACE, kinins and NO. Cardiovascular research, 1999, Aug-15, Volume: 43, Issue:3 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Biological Availability; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertension; Kinins; Myocardial Ischemia; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Ventricular Remodeling	1999
Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacological reviews, 2000, Volume: 52, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Vessels; Cardiovascular Diseases; Heart; Humans; Kidney; Kidney Diseases; Receptors, Angiotensin	2000
Angiotensin II AT2 subtype receptors: an emerging target for cardiovascular therapy. Italian heart journal : official journal of the Italian Federation of Cardiology, 2000, Volume: 1, Issue:2 Topics: Angiotensin II; Animals; Blood Vessels; Cardiovascular Diseases; Humans; Myocardium; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction	2000
Irbesartan: an updated review of its use in cardiovascular disorders. Drugs, 2000, Volume: 59, Issue:5 Topics: Angiotensin II; Animals; Biphenyl Compounds; Cardiovascular Diseases; Humans; Irbesartan; Receptors, Angiotensin; Tetrazoles	2000
[A role of angiotensin II found in knockout mice with angiotensin signal breakdown]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2000, Volume: 37, Issue:3 Topics: Aging; Angiotensin II; Animals; Blood Pressure; Blood-Brain Barrier; Brain; Cardiovascular Diseases; Humans; Hypertension; Mice; Mice, Knockout; Nerve Regeneration; Renin-Angiotensin System; Risk Factors	2000
Factors affecting circadian variability. Blood pressure monitoring, 2000, Volume: 5 Suppl 1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Cardiovascular Diseases; Circadian Rhythm; Humans; Hypertension; Receptors, Angiotensin; Renin-Angiotensin System; Vasoconstrictor Agents	2000
Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockers. Current opinion in nephrology and hypertension, 2000, Volume: 9, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular Diseases; Hemodynamics; Humans; Hypertension; Kidney Diseases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Renin-Angiotensin System	2000
Treating high-risk diabetic hypertensive patients with comorbid conditions. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:3 Suppl 1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Disease Progression; Humans; Hypertension; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors	2000
Apoptosis induction and inhibition of cellular proliferation by angiotensin II: possible implication and perspectives. Acta physiologica Hungarica, 2000, Volume: 87, Issue:1 Topics: Angiotensin II; Animals; Apoptosis; Cardiovascular Diseases; Cell Division; Humans; Kidney Diseases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction	2000
Angiotensin II mediated signal transduction. Important role of tyrosine kinases. Regulatory peptides, 2000, Nov-24, Volume: 95, Issue:1-3 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Humans; Hypertension; Kidney Diseases; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Renin-Angiotensin System; Signal Transduction	2000
The role of angiotensin II receptor antagonists in hypertension management: focus on candesartan cilexetil. Journal of human hypertension, 2000, Volume: 14 Suppl 2 Topics: Adult; Age Factors; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Hypertension; Life Style; Male; Middle Aged; Patient Compliance; Practice Guidelines as Topic; Prevalence; Prodrugs; Prospective Studies; Risk; Risk Factors; Sex Factors; Tetrazoles; Time Factors; World Health Organization	2000
Angiotensin, inflammation, hypertension, and cardiovascular disease. Current hypertension reports, 2001, Volume: 3, Issue:1 Topics: Angiotensin II; Cardiovascular Diseases; Humans; Hypertension; Inflammation; NF-kappa B; Vasoconstrictor Agents	2001
Effects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin. Diabetes, obesity & metabolism, 2000, Volume: 2, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Hemodynamics; Humans; Insulin; Insulin Resistance; Models, Animal; Muscle, Smooth, Vascular; Natriuresis; Receptors, Angiotensin; Renin-Angiotensin System; Sympathetic Nervous System	2000
Oxidative stress and vascular damage in hypertension. Current opinion in nephrology and hypertension, 2001, Volume: 10, Issue:2 Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Blood Vessels; Cardiovascular Diseases; Disease Models, Animal; Estrogens; Gene Transfer Techniques; Humans; Hydrogen Peroxide; Hypertension; Mitochondria; NADH, NADPH Oxidoreductases; NADPH Oxidases; Nitrates; Nitric Oxide Synthase; Oxidative Stress; Rats; Reactive Oxygen Species; Renin-Angiotensin System; Risk Factors; Signal Transduction; Superoxide Dismutase; Vitamins; Xanthine Oxidase	2001
Workshop: hypertension and cardiovascular risk factors: role of the angiotensin II-nitric oxide interaction. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:2 Pt 2 Topics: Albuminuria; Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Complications; Endothelium, Vascular; Homeostasis; Humans; Hypertension; Nitric Oxide; Nitric Oxide Synthase; Renin-Angiotensin System; Risk Factors; Superoxides	2001
Expanded role for ARBs in cardiovascular and renal disease? Recent observations have far-reaching implications. Postgraduate medicine, 2001, Volume: 109, Issue:4 Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biological Availability; Biphenyl Compounds; Cardiovascular Diseases; Humans; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Metabolic Clearance Rate; Patient Selection; Renin-Angiotensin System; Telmisartan; Tetrazoles; Thiophenes; Treatment Outcome; Valine; Valsartan	2001
Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. The American journal of cardiology, 2001, Apr-19, Volume: 87, Issue:8A Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Humans; Kidney Diseases; Renin-Angiotensin System; Risk Factors	2001
Angiotensin II and the pathophysiology of cardiovascular remodeling. The American journal of cardiology, 2001, Apr-19, Volume: 87, Issue:8A Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Humans; Hypertension; Renin-Angiotensin System; Transforming Growth Factor beta	2001
Aldosterone as a determinant of cardiovascular and renal dysfunction. Journal of the Royal Society of Medicine, 2001, Volume: 94, Issue:8 Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Endothelium, Vascular; Fibrosis; Humans; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Nitric Oxide; Potassium; Randomized Controlled Trials as Topic; Sodium; Spironolactone	2001
[Resistance to ACE inhibitors. Myth or reality?]. Archives des maladies du coeur et des vaisseaux, 2001, Volume: 94, Issue:9 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Drug Resistance; Humans; Hypertension; Renin-Angiotensin System; Ventricular Remodeling	2001
Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal diseases. Current opinion in nephrology and hypertension, 2002, Volume: 11, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Disease Progression; Endothelins; Humans; Inflammation; Kidney Diseases; Nitric Oxide; Receptor, Angiotensin, Type 1	2002
Novel angiotensin II inhibitors in cardiovascular medicine. Expert opinion on investigational drugs, 2001, Volume: 10, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Protease Inhibitors; Renin	2001
Genetic determinants of vascular reactivity. Current hypertension reports, 2002, Volume: 4, Issue:1 Topics: Angiotensin II; Blood Pressure; Blood Vessels; Cardiovascular Diseases; Endothelin-1; Endothelins; Genotype; Humans; Hypertension; Nitric Oxide Synthase; Polymorphism, Genetic; Protein Precursors; Renin-Angiotensin System	2002
The role of the renin-angiotensin system in the development of cardiovascular disease. The American journal of cardiology, 2002, Jan-24, Volume: 89, Issue:2A Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteriosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertrophy, Left Ventricular; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System	2002
Angiotensin II as a cardiovascular risk factor. Journal of human hypertension, 2002, Volume: 16 Suppl 2 Topics: Angiotensin II; Animals; Blood Flow Velocity; Cardiovascular Diseases; Endothelium, Vascular; Humans; Renin-Angiotensin System; Risk Assessment; Risk Factors	2002
Blockade of the renin-angiotensin system. Hong Kong medical journal = Xianggang yi xue za zhi, 2002, Volume: 8, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Humans; Hypertension; Receptors, Angiotensin; Renin-Angiotensin System	2002
Role of hypertension in atherosclerosis and cardiovascular disease. The American journal of cardiology, 1976, Nov-23, Volume: 38, Issue:6 Topics: Angiotensin II; Animals; Antihypertensive Agents; Arteriosclerosis; Blood Platelets; Capillary Permeability; Cardiomegaly; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Death, Sudden; Endothelium; Histamine; Humans; Hypertension; Lipids; Lysosomes; Muscle, Smooth; Renin; Serotonin; Thrombosis	1976
Cardioprotection and ACE inhibitors. Clinical physiology and biochemistry, 1992, Volume: 9, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Hypertrophy, Left Ventricular; Myocardial Infarction; Prognosis	1992
Myocardial fibrosis and the concepts of cardioprotection and cardioreparation. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1992, Volume: 10, Issue:5 Topics: Angiotensin II; Cardiovascular Diseases; Endomyocardial Fibrosis; Humans; Mineralocorticoids; Risk Factors	1992
Angiotensin converting enzyme inhibition and its impact on cardiovascular disease. Circulation, 1990, Volume: 81, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Vessels; Cardiovascular Diseases; Forecasting; Humans	1990
[Does atrial antipressor natriuretic peptide play a pathophysiological role?]. Schweizerische medizinische Wochenschrift, 1987, Dec-05, Volume: 117, Issue:49 Topics: Angiotensin II; Atrial Natriuretic Factor; Cardiovascular Diseases; Humans; Natriuresis; Peptide Fragments; Renin; Renin-Angiotensin System; Vasodilation	1987
[The renin-angiotensin system in hypertension and heart insufficiency: current aspects in the use of ACE inhibitors]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1988, Jun-14, Volume: 77, Issue:24 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cushing Syndrome; Humans; Hypertension; Hypertension, Renovascular; Renin-Angiotensin System	1988
Tissue sensitivity to drugs in disease states. The Medical clinics of North America, 1974, Volume: 58, Issue:5 Topics: Aging; Angiotensin II; Animals; Atropine; Bartter Syndrome; Bone and Bones; Carbohydrate Metabolism; Cardiovascular Diseases; Drug Hypersensitivity; Gastric Mucosa; Gastrointestinal Diseases; Heart; Hematologic Diseases; Humans; Kidney Failure, Chronic; Parathyroid Diseases; Parathyroid Hormone; Pharmaceutical Preparations; Rabbits; Rats; Thyroid Diseases; Uremia; Vasopressins; Vitamin D	1974

Trials

14 trial(s) available for angiotensin ii and Cardiovascular Diseases

Article	Year
Aerobic exercise improves central blood pressure and blood pressure variability among patients with resistant hypertension: results of the EnRicH trial. Hypertension research : official journal of the Japanese Society of Hypertension, 2023, Volume: 46, Issue:6 Topics: Angiotensin II; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Exercise; Humans; Hypertension; Interferon-gamma; Nitric Oxide; Prospective Studies; Pulse Wave Analysis; Superoxide Dismutase; Vascular Stiffness	2023
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England journal of medicine, 2003, Jan-30, Volume: 348, Issue:5 Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins	2003
[Change of natural antibody levels in patients with cardiovascular diseases by the use of anti-atherogenic diets with processed soy product foods]. Voprosy pitaniia, 2002, Volume: 71, Issue:5 Topics: Adult; Aged; alpha-Macroglobulins; Angiotensin II; Antibodies; Antithrombin III; Cardiovascular Diseases; Cholesterol; Diet Therapy; Dietary Proteins; Female; Food Handling; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Soybean Oil; Soybean Proteins; Thrombin; Triglycerides	2002
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Annals of internal medicine, 2003, Apr-01, Volume: 138, Issue:7 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Placebos; Risk Factors; Tetrazoles; Treatment Outcome	2003
[The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes]. Ugeskrift for laeger, 2003, Jun-23, Volume: 165, Issue:26 Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins	2003
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. Diabetologia, 2005, Volume: 48, Issue:10 Topics: Aged; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Humans; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Risk Assessment; Treatment Outcome	2005
[Effect of anti-atherosclerotic diet with polyunsaturated fatty acids omega-3 from linseed oil on dynamics of natural antibodies to bradykinin and angiotensin II in blood serum of patients with cardiovascular diseases]. Voprosy pitaniia, 1998, Issue:2 Topics: Adult; Angiotensin II; Antibodies; Arteriosclerosis; Bradykinin; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Humans; Hyperlipoproteinemias; Hypertension; Linseed Oil; Male; Middle Aged; Myocardial Ischemia	1998
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Blood pressure, 1998, Volume: 7, Issue:3 Topics: Aged; Amlodipine; Angiotensin II; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Tetrazoles; Treatment Outcome; Valine; Valsartan	1998
Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators. Cardiovascular drugs and therapy, 2000, Volume: 14, Issue:1 Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Renin-Angiotensin System; Single-Blind Method	2000
[Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy]. Ugeskrift for laeger, 2001, Oct-01, Volume: 163, Issue:40 Topics: Adult; Aged; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Humans; Losartan; Male; Middle Aged; Renin-Angiotensin System	2001
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes]. Ugeskrift for laeger, 2001, Oct-01, Volume: 163, Issue:40 Topics: Adult; Aged; Albuminuria; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Irbesartan; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles	2001
Low-dose estrogen supplementation improves vascular function in hypogonadal men. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:5 Topics: Acetylcholine; Angiotensin II; Blood Pressure; Cardiotonic Agents; Cardiovascular Diseases; Double-Blind Method; Estrogens; Hemodynamics; Humans; Hypogonadism; Lipids; Male; Nitroprusside; Norepinephrine; omega-N-Methylarginine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents	2001
Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women. Circulation, 2002, Jan-22, Volume: 105, Issue:3 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Postmenopause; Ramipril; Renin; Single-Blind Method; Tissue Plasminogen Activator	2002

Other Studies

144 other study(ies) available for angiotensin ii and Cardiovascular Diseases

Article	Year
Allergic asthma aggravates angiotensin Ⅱ-induced cardiac remodeling in mice. Translational research : the journal of laboratory and clinical medicine, 2022, Volume: 244 Topics: Angiotensin II; Animals; Asthma; Bronchoalveolar Lavage Fluid; Cardiovascular Diseases; Disease Models, Animal; Heart Failure; Immunoglobulin E; Mice; Mice, Inbred BALB C; Nutrition Surveys; Ovalbumin; Ventricular Remodeling	2022
Short-Term Pharmacological Induction of Arterial Stiffness and Hypertension with Angiotensin II Does Not Affect Learning and Memory and Cerebral Amyloid Load in Two Murine Models of Alzheimer's Disease. International journal of molecular sciences, 2022, Mar-01, Volume: 23, Issue:5 Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidogenic Proteins; Amyloidosis; Angiotensin II; Animals; Cardiovascular Diseases; Disease Models, Animal; Hypertension; Mice; Vascular Stiffness	2022
Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic Cancer. Current cancer drug targets, 2022, Volume: 22, Issue:10 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Humans; Pancreatic Neoplasms; Prospective Studies	2022
Transcriptomics of angiotensin II-induced long noncoding and coding RNAs in endothelial cells. Journal of hypertension, 2022, 07-01, Volume: 40, Issue:7 Topics: Angiotensin II; Cardiovascular Diseases; Human Umbilical Vein Endothelial Cells; Humans; RNA, Long Noncoding; RNA, Messenger; Transcriptome	2022
Mouse endothelial OTUD1 promotes angiotensin II-induced vascular remodeling by deubiquitinating SMAD3. EMBO reports, 2023, 03-06, Volume: 24, Issue:3 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Chromatography, Liquid; Mice; Tandem Mass Spectrometry; Vascular Remodeling	2023
Sesamin suppresses angiotensin-II-enhanced oxidative stress and hypertrophic markers in H9c2 cells. Environmental toxicology, 2023, Volume: 38, Issue:9 Topics: Angiotensin II; Cardiomegaly; Cardiovascular Diseases; Humans; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species	2023
Identification of membrane palmitoylated protein 1 (MPP1) as a heart-failure-promoting protein triggered by cardiovascular risk factors and aging. Biochemical pharmacology, 2023, Volume: 217 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Heart Failure; Humans; Mice; Mice, Transgenic; Myocardium; Receptor, Angiotensin, Type 1; Risk Factors; Stroke Volume; Ventricular Function, Left	2023
The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart. Cell death & disease, 2019, 08-14, Volume: 10, Issue:8 Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; bcl-2-Associated X Protein; Calcineurin; Cardiovascular Diseases; Cyclin D1; Gene Expression Regulation; Glucose Transporter Type 4; Humans; Hypertrophy; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Primary Cell Culture; Rats; RNA, Small Interfering; Transcription Factor Brn-3B	2019
Soluble RAGE attenuates AngII-induced endothelial hyperpermeability by disrupting HMGB1-mediated crosstalk between AT1R and RAGE. Experimental & molecular medicine, 2019, 09-27, Volume: 51, Issue:9 Topics: Angiotensin II; Animals; Antigens, CD; Antigens, Neoplasm; Aorta; Atherosclerosis; Cadherins; Capillary Permeability; Cardiovascular Diseases; Endothelial Cells; HMGB1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Inflammation; Ligands; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Receptor, Angiotensin, Type 1; RNA, Small Interfering; Signal Transduction	2019
Continuous hemodiafiltration as a rescue therapy for patients with cardiopulmonary failure caused by enterovirus-71: a retrospective observational study in a PICU. BMC infectious diseases, 2019, Oct-21, Volume: 19, Issue:1 Topics: Aldosterone; Angiotensin II; Cardiovascular Diseases; Catecholamines; Child, Preschool; China; Continuous Renal Replacement Therapy; Enterovirus A, Human; Female; Follow-Up Studies; Hand, Foot and Mouth Disease; Hemodiafiltration; Humans; Infant; Intensive Care Units, Pediatric; Male; Pulmonary Disease, Chronic Obstructive; Renin; Renin-Angiotensin System; Retrospective Studies; Stroke Volume; Treatment Outcome	2019
T-cell senescence accelerates angiotensin II-induced target organ damage. Cardiovascular research, 2021, 01-01, Volume: 117, Issue:1 Topics: Adoptive Transfer; Angiotensin II; Animals; Aorta; Cardiovascular Diseases; Cell Line; Disease Models, Animal; Homeodomain Proteins; Humans; Hypertension; Immunosenescence; Inflammation Mediators; Interferon-gamma; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Oxidative Stress; Phenotype; Superoxides; T-Lymphocytes; Time Factors	2021
Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System? A Call for Epidemiologic Investigations. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 07-28, Volume: 71, Issue:15 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Renin-Angiotensin System; SARS-CoV-2; Severe Acute Respiratory Syndrome	2020
The protein Deleted in Breast Cancer-1 (DBC1) regulates vascular response and formation of aortic dissection during Angiotensin II infusion. Scientific reports, 2020, 04-21, Volume: 10, Issue:1 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Cell Cycle Proteins; Cell Proliferation; Disease Models, Animal; Humans; Hypertension; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Nerve Tissue Proteins; Vascular Endothelial Growth Factor A; Vascular System Injuries	2020
Using 4-vinylcyclohexene diepoxide as a model of menopause for cardiovascular disease. American journal of physiology. Heart and circulatory physiology, 2020, 06-01, Volume: 318, Issue:6 Topics: Angiotensin II; Animals; Atrial Remodeling; Blood Pressure; Cardiovascular Diseases; Cyclohexenes; Female; Menopause; Mice; Models, Animal; Vinyl Compounds	2020
Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications. General physiology and biophysics, 2020, Volume: 39, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Renin-Angiotensin System; SARS-CoV-2; Virus Internalization	2020
COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease. Medical hypotheses, 2020, Volume: 144 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Anticoagulants; Cardiovascular Diseases; COVID-19; Humans; Hypertension; Models, Theoretical; Peptide Fragments; Renin-Angiotensin System; Respiration; Risk Factors; Venous Thromboembolism; Virus Internalization	2020
MicroRNA-99b-3p promotes angiotensin II-induced cardiac fibrosis in mice by targeting GSK-3β. Acta pharmacologica Sinica, 2021, Volume: 42, Issue:5 Topics: 3' Untranslated Regions; Angiotensin II; Animals; Antagomirs; Cardiovascular Diseases; Fibroblasts; Fibrosis; Glycogen Synthase Kinase 3 beta; Male; Mice, Inbred C57BL; MicroRNAs; Myocardium; Rats, Sprague-Dawley; Up-Regulation	2021
A Dual Role of Heme Oxygenase-1 in Angiotensin II-Induced Abdominal Aortic Aneurysm in the Normolipidemic Mice. Cells, 2021, 01-15, Volume: 10, Issue:1 Topics: Aneurysm; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Cardiovascular Diseases; Cell Line; Collagen; Genotype; Heme Oxygenase-1; Humans; Hyperlipidemias; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Oxidative Stress; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 2; Serpin E2; Skin; Swine; Tissue Inhibitor of Metalloproteinase-2	2021
Characterization of the Renin-Angiotensin-Aldosterone System in Young Healthy Black Adults: The African Prospective Study on the Early Detection and Identification of Hypertension and Cardiovascular Disease (African-PREDICT Study). Hypertension (Dallas, Tex. : 1979), 2021, Volume: 78, Issue:2 Topics: Adult; Aldosterone; Angiotensin II; Black People; Blood Pressure; Cardiovascular Diseases; Early Diagnosis; Female; Healthy Volunteers; Humans; Hypertension; Male; Prospective Studies; Renin-Angiotensin System; White People; Young Adult	2021
Agomelatine prevents angiotensin II-induced endothelial and mononuclear cell adhesion. Aging, 2021, 07-22, Volume: 13, Issue:14 Topics: Acetamides; Angiotensin II; Cardiovascular Diseases; Cell Adhesion; Chemokine CCL2; Early Growth Response Protein 1; Endothelial Cells; Endothelium, Vascular; Humans; Leukocytes, Mononuclear; Signal Transduction; Vascular Cell Adhesion Molecule-1	2021
miR-181b regulates vascular stiffness age dependently in part by regulating TGF-β signaling. PloS one, 2017, Volume: 12, Issue:3 Topics: Aging; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiovascular Diseases; Endothelial Cells; Extracellular Matrix; Hypertension; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Nitric Oxide; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Vascular Stiffness	2017
[Irbesartan ameliorates cardiac inflammation in type 2 diabetic db/db mice]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2016, Apr-20, Volume: 37, Issue:4 Topics: Actins; Angiotensin II; Animals; Biphenyl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Inflammation; Interleukin-6; Irbesartan; Mice; Obesity; Random Allocation; Real-Time Polymerase Chain Reaction; Signal Transduction; Tetrazoles; Transcription Factor RelA; Tumor Necrosis Factor-alpha	2016
Rho-kinase and the nitric oxide pathway modulate basilar arterial reactivity to acetylcholine and angiotensin II in streptozotocin-induced diabetic mice. Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:9 Topics: Acetylcholine; Amides; Angiotensin II; Animals; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Male; Mice; Mice, Inbred ICR; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyridines; rho-Associated Kinases; Streptozocin; Time Factors	2017
Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release. JCI insight, 2018, 04-19, Volume: 3, Issue:8 Topics: Adipocytes; Adiponectin; Angiotensin II; Animals; Aorta; Cadherins; Cardiovascular Diseases; Cells, Cultured; Ceramides; Endothelial Cells; Exosomes; Male; Mice; Mice, Knockout; Organelle Biogenesis	2018
CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease. Circulation research, 2018, 07-20, Volume: 123, Issue:3 Topics: 3T3 Cells; Angiotensin II; Animals; Cardiovascular Diseases; Cell Proliferation; Cells, Cultured; CRISPR-Cas Systems; Cytokines; Dioxygenases; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA-Binding Proteins; Gene Silencing; HEK293 Cells; Hematopoiesis; Hematopoietic Stem Cells; Humans; Macrophages; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins	2018
Serum containing Buyang Huanwu decoction prevents age-associated migration and invasion of human vascular smooth muscle cells by up regulating SIRT1 expression. Bioscience trends, 2018, Jul-17, Volume: 12, Issue:3 Topics: Aging; Angiotensin II; Aorta; Cardiovascular Diseases; Cell Movement; Cell Proliferation; Cells, Cultured; Cellular Senescence; Down-Regulation; Drugs, Chinese Herbal; Gene Knockdown Techniques; Humans; Matrix Metalloproteinase 2; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Up-Regulation	2018
Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II. Scientific reports, 2018, 08-17, Volume: 8, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Cardiovascular Diseases; Disease Models, Animal; Echocardiography; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Gene Expression; Male; Mice; Mice, Knockout; Myocardium; Rats; Rodentia; Signal Transduction	2018
Angiotensin 1-7 suppresses angiotensin II mediated aldosterone production via JAK/STAT signaling inhibition. The Journal of steroid biochemistry and molecular biology, 2019, Volume: 185 Topics: Adrenocortical Carcinoma; Aldosterone; Angiotensin I; Angiotensin II; Cardiovascular Diseases; Cell Line, Tumor; Culture Media, Conditioned; Cytochrome P-450 CYP11B2; Humans; Janus Kinases; Peptide Fragments; Phosphorylation; Signal Transduction; STAT Transcription Factors	2019
Angiotensin II- and Alzheimer-Type Cardiovascular Aging. Circulation research, 2018, 08-31, Volume: 123, Issue:6 Topics: Age Factors; Aging; Alzheimer Disease; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Autophagy; Brain; Cardiovascular Diseases; Cardiovascular System; Cellular Senescence; Humans; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Unfolded Protein Response	2018
Development and application of low-cost T-ARMS-PCR assay for AGT and CYP11B1 gene polymorphisms. Molecular biology reports, 2019, Volume: 46, Issue:1 Topics: Alleles; Angiotensin II; Angiotensinogen; Blood Pressure; Cardiovascular Diseases; Female; Gene Frequency; Genotype; Genotyping Techniques; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Renin-Angiotensin System; Steroid 11-beta-Hydroxylase	2019
Proinflammatory Role of Angiotensin II in the Aorta of Normotensive Mice. BioMed research international, 2019, Volume: 2019 Topics: Actins; Angiotensin II; Animals; Aorta; Blood Pressure; Cardiovascular Diseases; Gene Expression Regulation; Humans; Interleukin-1beta; Leukocyte Common Antigens; Mice; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type II; Saline Solution; Transforming Growth Factor beta	2019
Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling. Biochemical and biophysical research communications, 2019, 05-14, Volume: 512, Issue:4 Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Anticholesteremic Agents; Cardiovascular Diseases; Cell Cycle Proteins; Cell Line; Fibrosis; Lovastatin; Male; Mice, Inbred C57BL; Myocardium; Signal Transduction; Trans-Activators; YAP-Signaling Proteins	2019
Identifying a disease-specific renin-angiotensin-aldosterone system fingerprint in patients with primary adrenal insufficiency. European journal of endocrinology, 2019, Jul-01, Volume: 181, Issue:1 Topics: Addison Disease; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Angiotensins; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Hydrocortisone; Male; Middle Aged; Renin; Renin-Angiotensin System; Risk Factors	2019
Critical role of the endogenous renin-angiotensin system in maintaining self-renewal and regeneration potential of epidermal stem cells. Biochimica et biophysica acta. Molecular basis of disease, 2019, 10-01, Volume: 1865, Issue:10 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Captopril; Cardiovascular Diseases; Cell Movement; Cell Proliferation; Epidermal Cells; Humans; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Regeneration; Renin-Angiotensin System; Skin; STAT1 Transcription Factor; STAT3 Transcription Factor; Stem Cells; Wound Healing	2019
Evolving concepts of the renin-angiotensin system: highlights from the pre-ISH 2012 satellite meeting. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2013, Volume: 14, Issue:1 Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cardiovascular Diseases; Clinical Trials as Topic; Cystinyl Aminopeptidase; Female; Humans; Male; Mice; Protein Multimerization; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Sex Characteristics; Signal Transduction	2013
Decrease in blood pressure and regression of cardiovascular complications by angiotensin II vaccine in mice. PloS one, 2013, Volume: 8, Issue:3 Topics: Angiotensin II; Animals; Antibodies, Neutralizing; Antibody Formation; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Immunization; Kidney; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Models, Cardiovascular; Myocardium; Rats; Rats, Inbred SHR; T-Lymphocytes; Vaccines; Ventricular Remodeling	2013
White blood cell count in women: relation to inflammatory biomarkers, haematological profiles, visceral adiposity, and other cardiovascular risk factors. Journal of health, population, and nutrition, 2013, Volume: 31, Issue:1 Topics: Adipose Tissue; Adult; Angiotensin II; Biomarkers; Blood Platelets; Body Composition; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Female; Humans; Inflammation; Interleukin-6; Intra-Abdominal Fat; Leukocyte Count; Lipids; Obesity; Population Surveillance; Risk Factors; Waist Circumference	2013
Vitamin D levels are associated with cardiac autonomic activity in healthy humans. Nutrients, 2013, Jun-10, Volume: 5, Issue:6 Topics: Adult; Angiotensin II; Autonomic Nervous System; Blood Pressure; Cardiovascular Diseases; Electrocardiography; Female; Heart Rate; Humans; Male; Risk Factors; Vitamin D; Vitamin D Deficiency	2013
Melatonin ameliorates angiotensin II-induced vascular endothelial damage via its antioxidative properties. Journal of pineal research, 2013, Volume: 55, Issue:3 Topics: Angiotensin II; Antioxidants; Cardiovascular Diseases; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Humans; Melatonin; NADPH Oxidases; Reactive Oxygen Species; Vasoconstrictor Agents	2013
Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis. Journal of hypertension, 2014, Volume: 32, Issue:4 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Cardiovascular Diseases; Disease Models, Animal; Echocardiography; Endothelium, Vascular; Heart Ventricles; Hemodynamics; Hypertension; Imidazoles; Male; Oxidative Stress; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley	2014
Phenotype-genotype analysis in two Chinese families with Liddle syndrome. Molecular biology reports, 2014, Volume: 41, Issue:3 Topics: Angiotensin II; Asian People; Cardiovascular Diseases; Death, Sudden; Epithelial Sodium Channels; Exons; Female; Genetic Association Studies; Humans; Hypertension; Liddle Syndrome; Male; Mutation; Pedigree; Potassium	2014
Induction of microRNA-138 by pro-inflammatory cytokines causes endothelial cell dysfunction. FEBS letters, 2014, Mar-18, Volume: 588, Issue:6 Topics: Angiotensin II; Cardiovascular Diseases; Cell Line; Endothelial Cells; Endothelin-1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; MAP Kinase Signaling System; MicroRNAs; Mitogen-Activated Protein Kinases; Nitric Oxide Synthase Type III; Phosphorylation; Protein Processing, Post-Translational; S100 Proteins; Transcriptional Activation; Tumor Necrosis Factor-alpha	2014
Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421. Clinical science (London, England : 1979), 2014, Volume: 127, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Cardiovascular Diseases; Down-Regulation; Gene Expression Regulation; Humans; MicroRNAs; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Transcription, Genetic	2014
Effects of moderate strength cold air exposure on blood pressure and biochemical indicators among cardiovascular and cerebrovascular patients. International journal of environmental research and public health, 2014, Feb-27, Volume: 11, Issue:3 Topics: Adult; Aged; Air; Angiotensin II; Biomarkers; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Catecholamines; Cerebrovascular Disorders; Cold Temperature; Endothelin-1; Female; Humans; Male; Middle Aged; Myoglobin; Troponin I	2014
Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk. Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:6 Topics: Age Factors; Aldosterone; Angiotensin II; Blood Pressure; Cardiovascular Diseases; Cross-Sectional Studies; Diet, Sodium-Restricted; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Linear Models; Male; Middle Aged; Multivariate Analysis; p-Aminohippuric Acid; Prognosis; Renal Plasma Flow; Risk Factors; Sodium, Dietary	2014
Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes. Endocrine, 2015, Volume: 48, Issue:1 Topics: 3T3-L1 Cells; Adipocytes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antioxidants; Captopril; Cardiovascular Diseases; Mice; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Uric Acid	2015
New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases. PloS one, 2014, Volume: 9, Issue:4 Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Female; Genotype; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Serum Albumin	2014
Dissociating angiotensin 1-9 anticardiovascular remodeling effects from those on blood pressure. Journal of hypertension, 2014, Volume: 32, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Hypertension; Male; Peptide Fragments	2014
Reply: dissociating angiotensin 1-9 anticardiovascular remodeling effects from those on blood pressure. Journal of hypertension, 2014, Volume: 32, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Hypertension; Male; Peptide Fragments	2014
Testosterone is associated with the cardiovascular autonomic response to a stressor in healthy men. Clinical and experimental hypertension (New York, N.Y. : 1993), 2015, Volume: 37, Issue:3 Topics: Adult; Angiotensin II; Autonomic Nervous System; Cardiovascular Diseases; Cardiovascular System; Female; Gonadal Steroid Hormones; Healthy Volunteers; Heart Rate; Humans; Male; Middle Aged; Risk Factors; Sex Factors; Statistics as Topic; Testosterone	2015
Cardiovascular dysfunction in adult mice following postnatal intermittent hypoxia. Pediatric research, 2015, Volume: 77, Issue:3 Topics: Age Factors; Angiotensin II; Angiotensinogen; Animals; Animals, Newborn; Baroreflex; Blood Pressure; Cardiovascular Diseases; DNA Methylation; Heart Rate; Hypoxia; Mice; Mice, Inbred C57BL; Renin-Angiotensin System	2015
Consumption of polyphenol-rich peach and plum juice prevents risk factors for obesity-related metabolic disorders and cardiovascular disease in Zucker rats. The Journal of nutritional biochemistry, 2015, Volume: 26, Issue:6 Topics: Angiotensin II; Animals; Biomarkers; Cardiovascular Diseases; Chemokine CCL2; Fruit and Vegetable Juices; Insulin; Intercellular Adhesion Molecule-1; Leptin; Male; Metabolic Syndrome; NF-kappa B; Obesity; Polyphenols; PPAR gamma; Prunus domestica; Prunus persica; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Risk Factors; RNA, Messenger; Weight Gain	2015
Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2. Journal of molecular medicine (Berlin, Germany), 2015, Volume: 93, Issue:9 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Humans; Male; Mice; Mice, Inbred C57BL; Myocardium; Nitric Oxide Synthase Type III; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Signal Transduction	2015
Losartan treatment attenuates tumor-induced myocardial dysfunction. Journal of molecular and cellular cardiology, 2015, Volume: 85 Topics: Adenocarcinoma; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Signaling; Cardiotonic Agents; Cardiovascular Diseases; Cell Line, Tumor; Colonic Neoplasms; Cytokines; Drug Evaluation, Preclinical; Female; Glutathione; Losartan; Mice; Myocardium; Neoplasm Transplantation; Tumor Burden; Ventricular Remodeling	2015
Contractile Function During Angiotensin-II Activation: Increased Nox2 Activity Modulates Cardiac Calcium Handling via Phospholamban Phosphorylation. Journal of the American College of Cardiology, 2015, Jul-21, Volume: 66, Issue:3 Topics: Angiotensin II; Animals; Calcium; Calcium-Binding Proteins; Cardiovascular Diseases; Disease Models, Animal; Membrane Glycoproteins; Mice; Mice, Transgenic; Models, Cardiovascular; Myocardial Contraction; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Phosphorylation; Reactive Oxygen Species; Renin-Angiotensin System; Sarcoplasmic Reticulum	2015
From Contractile Enhancement to Pathological Hypertrophy: Angiotensin II-Induced Nox2-Mediated Reactive Oxygen Species. Journal of the American College of Cardiology, 2015, Jul-21, Volume: 66, Issue:3 Topics: Angiotensin II; Animals; Calcium; Calcium-Binding Proteins; Cardiovascular Diseases; Membrane Glycoproteins; Myocardial Contraction; Myocytes, Cardiac; NADPH Oxidases	2015
Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways. PloS one, 2015, Volume: 10, Issue:9 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Cell Movement; Cell Proliferation; Cells, Cultured; Exenatide; Glucagon-Like Peptide-1 Receptor; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Peptides; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Venoms	2015
Orphan Nuclear Receptor Nur77 Inhibits Angiotensin II-Induced Vascular Remodeling via Downregulation of β-Catenin. Hypertension (Dallas, Tex. : 1979), 2016, Volume: 67, Issue:1 Topics: Angiotensin II; Animals; beta Catenin; Cardiovascular Diseases; Disease Models, Animal; DNA; Down-Regulation; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Nuclear Receptor Subfamily 4, Group A, Member 1; Vascular Remodeling	2016
Differential roles of NOX1/NADPH oxidase derived ROS in cardiovascular disease. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2016, Volume: 147, Issue:1 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Humans; NADPH Oxidases; Reactive Oxygen Species; Risk Factors	2016
Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study. Digestive diseases and sciences, 2016, Volume: 61, Issue:10 Topics: Administration, Intravenous; Aged; Albumins; Aldosterone; Angiotensin II; Ascites; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Norepinephrine; Odds Ratio; Paracentesis; Pilot Projects; Portasystemic Shunt, Transjugular Intrahepatic; Renin; Risk Factors	2016
The Renin-Angiotensin-Aldosterone System in Smokers and Non-Smokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Advances in experimental medicine and biology, 2016, Volume: 935 Topics: Aged; Aldosterone; Angiotensin I; Angiotensin II; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Female; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Renin; Renin-Angiotensin System; Smoking; Survival Rate	2016
Uric acid stimulates proliferative pathways in vascular smooth muscle cells through the activation of p38 MAPK, p44/42 MAPK and PDGFRβ. Journal of receptor and signal transduction research, 2017, Volume: 37, Issue:2 Topics: Angiotensin II; Animals; Atherosclerosis; Cardiovascular Diseases; Cell Proliferation; Gene Expression Regulation; Humans; Hypertension; Hyperuricemia; Losartan; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Receptor, Angiotensin, Type 1; Receptor, Platelet-Derived Growth Factor beta; Uric Acid	2017
Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D. Journal of hypertension, 2016, Volume: 34, Issue:11 Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Cardiovascular Diseases; Cholecalciferol; Endothelium; Essential Hypertension; Female; Humans; Hypertension; Male; Middle Aged; Pulse Wave Analysis; Renin; Renin-Angiotensin System; Vasodilation; Vitamin D; Vitamin D Deficiency; Vitamins	2016
Influence of sedentary versus physically active conditions on regulation of plasma renin activity and vasopressin. American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 295, Issue:3 Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Cardiovascular Diseases; Heart Rate; Male; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Risk Factors; Running	2008
The flame that lights the fire: oxidative stress, inflammation, and renal damage in angiotensin II-induced hypertension. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:2 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Disease Models, Animal; Hypertension; Inflammation; Inflammation Mediators; Kidney Diseases; Mice; Mice, Knockout; Oxidative Stress	2008
Future directions in cardiovascular pharmacology: examples from the Renin-Angiotensin system. Molecular interventions, 2008, Volume: 8, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Cardiovascular Diseases; Cardiovascular System; Humans; Pharmaceutical Preparations; Renin; Renin-Angiotensin System	2008
ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET. Therapeutic advances in cardiovascular disease, 2008, Volume: 2, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Kidney Diseases; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan	2008
5-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:2 Topics: Adult; Aged; Angiotensin II; Brachial Artery; Cardiovascular Diseases; Colonic Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Up-Regulation; Vasoconstriction	2010
Ventral lamina terminalis mediates enhanced cardiovascular responses of rostral ventrolateral medulla neurons during increased dietary salt. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:2 Topics: Analysis of Variance; Angiotensin II; Animals; Blood Pressure Determination; Cardiovascular Diseases; Disease Models, Animal; Hemodynamics; Hypertension; Hypothalamus; Male; Medulla Oblongata; Neural Inhibition; Neurons; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Risk Factors; Sensitivity and Specificity; Sodium Chloride, Dietary; Sympathetic Nervous System	2009
Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea. The European respiratory journal, 2009, Volume: 34, Issue:6 Topics: Adult; Angiotensin II; Aorta; Cardiovascular Diseases; Coculture Techniques; Continuous Positive Airway Pressure; Endothelial Cells; Humans; Immunoblotting; Leukocytes, Mononuclear; Lipoproteins, LDL; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Risk; Scavenger Receptors, Class E; Umbilical Veins; Vascular Endothelial Growth Factor A	2009
Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3 Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Cardiovascular System; Drug Synergism; Drug Therapy, Combination; Fumarates; Gene Expression; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Nitric Oxide Synthase Type III; Receptor, Angiotensin, Type 1; Renin; RNA, Messenger; Superoxides; Tetrazoles; Tunica Intima; Valine; Valsartan	2009
Moving beyond angiotensin II to also target aldosterone? Journal of the American College of Cardiology, 2009, Aug-04, Volume: 54, Issue:6 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Renin-Angiotensin System; Risk Factors	2009
The complex field of interplay between vasoactive agents. Kidney international, 2009, Volume: 76, Issue:9 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Angiotensin II; Animals; Arterioles; Calcium Signaling; Cardiovascular Diseases; Humans; Kidney; Mice; Myosin Light Chains; Myosin-Light-Chain Phosphatase; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Renal Circulation; Vasoconstriction	2009
Losartan-antioxidant hybrids: novel molecules for the prevention of hypertension-induced cardiovascular damage. Journal of medicinal chemistry, 2009, Nov-26, Volume: 52, Issue:22 Topics: Alcohols; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Blood Pressure; Cardiovascular Diseases; Cells, Cultured; Collagen Type I; Esters; Fibronectins; Humans; Hypertension; Losartan; Male; Oxidative Stress; Rats; Rats, Wistar	2009
PGC-1 alpha serine 570 phosphorylation and GCN5-mediated acetylation by angiotensin II drive catalase down-regulation and vascular hypertrophy. The Journal of biological chemistry, 2010, Jan-22, Volume: 285, Issue:4 Topics: Acetylation; Angiotensin II; Animals; Aorta, Thoracic; Cardiovascular Diseases; Catalase; Cells, Cultured; Down-Regulation; Forkhead Transcription Factors; Hypertrophy; Luciferases; Male; Muscle, Smooth, Vascular; Nerve Tissue Proteins; p300-CBP Transcription Factors; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Serine; Transcription Factors; Transcriptional Activation	2010
Hyperuricemia, cardiovascular disease, and the metabolic syndrome. The Journal of rheumatology, 2009, Volume: 36, Issue:12 Topics: Angiotensin II; Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Metabolic Syndrome; Obesity; Renin-Angiotensin System; Risk Factors; Uric Acid	2009
Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers. Arthritis and rheumatism, 2010, Volume: 62, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Arthritis, Experimental; Biphenyl Compounds; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Gene Expression; Hypertrophy; Irbesartan; Losartan; Male; Oxidative Stress; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Reduction Behavior; Tetrazoles; Vasoconstrictor Agents	2010
Role of the renin-angiotensin system in cardiovascular disease. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Disease Progression; Environment; Genetic Predisposition to Disease; Humans; Medication Therapy Management; Receptors, Angiotensin; Renin; Renin-Angiotensin System	2010
Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout mice. Free radical biology & medicine, 2010, Oct-15, Volume: 49, Issue:7 Topics: Actin Cytoskeleton; Angiotensin II; Animals; Aorta; Cardiovascular Diseases; Cell Line; Glutaredoxins; Hypertrophy; Infusion Pumps; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nitric Oxide Synthase Type II; Oncogene Protein v-akt; Oxidants; RNA, Small Interfering; Tyrosine	2010
Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) /IzmDmcr rats with metabolic syndrome. Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:11 Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Coronary Vessels; Cyclic GMP; Disease Models, Animal; Endothelium, Vascular; Insulin; Lipids; Metabolic Syndrome; Nitric Oxide; Nitroprusside; Oxidative Stress; Rats; Rats, Inbred Strains; Vasodilation	2010
Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation. Journal of immunology (Baltimore, Md. : 1950), 2010, Sep-15, Volume: 185, Issue:6 Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Cardiovascular Diseases; Cell Communication; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Female; Humans; Inflammation Mediators; Male; NF-kappa B; Ovariectomy; PPAR gamma; Rats; Rats, Sprague-Dawley; Resveratrol; Stereoisomerism; Stilbenes; Up-Regulation	2010
Acetylcholine prevents angiotensin II-induced oxidative stress and apoptosis in H9c2 cells. Apoptosis : an international journal on programmed cell death, 2011, Volume: 16, Issue:1 Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Atropine; bcl-2-Associated X Protein; Cardiotonic Agents; Cardiovascular Diseases; Caspase 3; Cells, Cultured; Gene Expression; Myocytes, Cardiac; NADPH Oxidases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Receptor, Angiotensin, Type 1	2011
Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production. Journal of hypertension, 2011, Volume: 29, Issue:4 Topics: Angiotensin II; Animals; Apelin; Cardiovascular Diseases; Fibrosis; Intercellular Signaling Peptides and Proteins; Male; Mice; Plasminogen Activator Inhibitor 1	2011
Angiotensin II modulates interleukin-1β-induced inflammatory gene expression in vascular smooth muscle cells via interfering with ERK-NF-κB crosstalk. Biochemical and biophysical research communications, 2011, Jul-08, Volume: 410, Issue:3 Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Cardiovascular Diseases; Down-Regulation; Dual Specificity Phosphatase 1; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Gene Knockdown Techniques; Inflammation; Interleukin-1beta; Mice; Mice, Mutant Strains; Muscle, Smooth, Vascular; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Ribosomal Protein S6 Kinases, 90-kDa; Vascular Cell Adhesion Molecule-1	2011
Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner. Journal of molecular and cellular cardiology, 2012, Volume: 52, Issue:1 Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Diseases; Disease Models, Animal; Female; Gene Expression; Gene Expression Profiling; Gene Knockout Techniques; Genetic Association Studies; Heart Failure; Hypertension; Hypertrophy, Right Ventricular; Kidney Diseases; Male; Mice; Mice, Knockout; Phenotype; Proto-Oncogene Proteins c-akt; Receptor Activity-Modifying Protein 3; Renin; Sex Factors	2012
Impact of gender on the cardiac autonomic response to angiotensin II in healthy humans. Journal of applied physiology (Bethesda, Md. : 1985), 2012, Volume: 112, Issue:6 Topics: Adult; Angiotensin II; Autonomic Nervous System; Cardiovascular Diseases; Female; Heart; Heart Rate; Hemodynamics; Humans; Male; Multivariate Analysis; Regression Analysis; Renin-Angiotensin System; Sex Factors; Vagus Nerve	2012
The Williams-Beuren Syndrome-a window into genetic variants leading to the development of cardiovascular disease. PLoS genetics, 2012, Volume: 8, Issue:2 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Chromosomes, Human, Pair 7; Genetic Variation; Genome, Human; Humans; Hypertension; Mice; Mice, Transgenic; Multienzyme Complexes; NADH, NADPH Oxidoreductases; NADPH Oxidases; Reactive Oxygen Species; Sequence Deletion; Williams Syndrome	2012
Angiotensin II and oxidative stress in the failing heart. Antioxidants & redox signaling, 2013, Oct-01, Volume: 19, Issue:10 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Heart Failure; Humans; Mitochondria; NADPH Oxidases; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System	2013
Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. The Journal of clinical investigation, 2012, Volume: 122, Issue:6 Topics: Angiotensin II; Animals; Biological Clocks; Calcium; Calcium Channels; Cardiovascular Diseases; Kidney Diseases; Male; Membrane Potentials; Mice; Potassium; Zona Glomerulosa	2012
Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes. Clinical science (London, England : 1979), 2012, Volume: 123, Issue:8 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aortic Diseases; Apoptosis; Biomarkers; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptidyl-Dipeptidase A; Plaque, Atherosclerotic; Telemetry	2012
Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced C-reactive protein production in macrophages. Pharmacological reports : PR, 2012, Volume: 64, Issue:4 Topics: Angiotensin II; Anti-Inflammatory Agents; C-Reactive Protein; Cardiovascular Diseases; Catechin; Cell Line, Tumor; Humans; Inflammation; Interleukin-6; Macrophages; Reactive Oxygen Species; RNA, Messenger; Tea; U937 Cells	2012
Artificial cold air increases the cardiovascular risks in spontaneously hypertensive rats. International journal of environmental research and public health, 2012, Sep-04, Volume: 9, Issue:9 Topics: Angiotensin II; Animals; Blood Chemical Analysis; Blood Pressure; Blood Viscosity; Body Weight; Cardiovascular Diseases; Cold Temperature; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Epinephrine; Fibrinogen; Heart Rate; Lipids; Male; Norepinephrine; Rats; Rats, Inbred SHR; Risk Factors; Vasoconstrictor Agents	2012
[Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective]. Nederlands tijdschrift voor geneeskunde, 2003, Jan-18, Volume: 147, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Cerebrovascular Disorders; Humans; Hypertension; Losartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Treatment Outcome	2003
Summaries for patients. Effects of blood pressure drugs in patients with diabetes and kidney disease. Annals of internal medicine, 2003, Apr-01, Volume: 138, Issue:7 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Placebos; Risk Factors; Tetrazoles; Treatment Outcome	2003
Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2003, Volume: 4, Issue:2 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Endothelium, Vascular; Humans; NADPH Oxidases; Oxidative Stress	2003
Cardiology patient page. What is an angiotensin converting enzyme inhibitor? Circulation, 2003, Jul-22, Volume: 108, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Cardiovascular Diseases; Contraindications; Drug Interactions; Humans; Hypertension; Patient Selection; Vasoconstriction	2003
Angiotensin-converting enzyme inhibitors: optimal management of cardiovascular risk. The American journal of cardiology, 2003, Oct-01, Volume: 92, Issue:7 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Evidence-Based Medicine; Humans; Hypertension; Losartan; Risk Management; Treatment Outcome	2003
Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury. Circulation, 2003, Nov-18, Volume: 108, Issue:20 Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Myocardium; NG-Nitroarginine Methyl Ester; Plasminogen Activator Inhibitor 1; Proteinuria; Sodium, Dietary; Spironolactone	2003
[Microalbuminuria is an early marker for increased morbidity and mortality]. Fortschritte der Medizin. Originalien, 2003, Feb-27, Volume: 121 Suppl 1 Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Losartan; Male; Meta-Analysis as Topic; Prevalence; Proteinuria; Renin-Angiotensin System; Risk Factors; Stroke	2003
Angiotensin II, platelets and oxidative stress. Journal of hypertension, 2004, Volume: 22, Issue:6 Topics: Angiotensin II; Blood Platelets; Cardiovascular Diseases; Endothelium, Vascular; Humans; Oxidative Stress; Receptor, Angiotensin, Type 1	2004
Angiotensin II: an amplifier of cardiovascular risk. Current hypertension reports, 2004, Volume: 6, Issue:4 Topics: Angiotensin II; Cardiovascular Diseases; Humans; Renin-Angiotensin System	2004
Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II. Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:9 Topics: Adenoviridae; Angiotensin II; Cardiovascular Diseases; Cell Movement; Cells, Cultured; Focal Adhesion Kinase 2; Gene Expression; Guanine Nucleotide Exchange Factors; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Protein Kinase C-delta; Protein Serine-Threonine Kinases; Receptor Cross-Talk; rho GTP-Binding Proteins; Rho Guanine Nucleotide Exchange Factors; rho-Associated Kinases; Vasoconstrictor Agents	2005
Role of oxidative stress in angiotensin-II mediated contraction of human conduit arteries in patients with cardiovascular disease. Vascular pharmacology, 2005, Volume: 43, Issue:4 Topics: Angiotensin II; Antioxidants; Arteries; Cardiovascular Diseases; Female; Humans; Isometric Contraction; Male; Mammary Arteries; Microscopy, Fluorescence; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Oxidants; Oxidation-Reduction; Oxidative Stress; Radial Artery; Renin-Angiotensin System; Superoxides	2005
[Role of cyclo-oxygenases in the effects of angiotensin II]. Medecine sciences : M/S, 2006, Volume: 22, Issue:1 Topics: Angiotensin II; Animals; Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Humans; Lactones; Models, Biological; Oxidative Stress; Sulfones	2006
The role of oxidant stress in angiotensin II-mediated contraction of human resistance arteries in the state of health and the presence of cardiovascular disease. Vascular pharmacology, 2006, Volume: 45, Issue:6 Topics: Aged; Angiotensin II; Antioxidants; Arteries; Ascorbic Acid; Cardiovascular Diseases; Cyclic N-Oxides; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Male; Oxidative Stress; Reactive Oxygen Species; Reference Values; Spin Labels; Subcutaneous Fat; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents	2006
Regulation of adrenomedullin release from human endothelial cells by sex steroids and angiotensin-II. The Journal of endocrinology, 2006, Volume: 191, Issue:1 Topics: Adrenomedullin; Angiotensin II; Aorta; Cardiovascular Diseases; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Estradiol; Female; Gonadal Steroid Hormones; Humans; Immunoblotting; Male; Radioimmunoassay; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stimulation, Chemical; Testosterone	2006
What is the role of angiotensin-receptor blockade in cardiovascular protection? American heart journal, 2006, Volume: 152, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Endothelium, Vascular; Humans; Kidney Diseases; Pilot Projects; Renin-Angiotensin System; Research Design; Vascular Diseases; Ventricular Remodeling	2006
Undernutrition in utero augments systolic blood pressure and cardiac remodeling in adult mouse offspring: possible involvement of local cardiac angiotensin system in developmental origins of cardiovascular disease. Endocrinology, 2007, Volume: 148, Issue:3 Topics: Angiotensin II; Animals; Blood Pressure; Cardiovascular Diseases; Female; Fetal Nutrition Disorders; Heart Ventricles; Leptin; Malnutrition; Mice; Mice, Inbred C57BL; Nitric Oxide; Pregnancy; Prenatal Exposure Delayed Effects; Renin-Angiotensin System; Sodium Glutamate; Ventricular Remodeling	2007
p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:3 Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Cardiovascular Diseases; Disease Models, Animal; Kidney Diseases; Male; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyrazoles; Rats; Rats, Sprague-Dawley; Renin	2007
The metabolic syndrome and the risk of thrombosis. Haematologica, 2007, Volume: 92, Issue:3 Topics: Adiponectin; Adipose Tissue; Angiotensin II; Anthropometry; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Cytokines; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Male; Metabolic Syndrome; Obesity; Plasminogen; Prevalence; Prospective Studies; Risk Factors; Stroke; Thrombophilia; Thrombosis; Tissue Plasminogen Activator	2007
Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. American journal of hypertension, 2007, Volume: 20, Issue:12 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Camellia sinensis; Cardiovascular Diseases; Endothelium, Vascular; Heart Rate; Heme Oxygenase-1; Hypertension; Male; NADPH Oxidases; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxide Dismutase; Superoxide Dismutase-1; Superoxides	2007
ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages. Archives of medical research, 2008, Volume: 39, Issue:2 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Cell Line; Chemokine CCL2; Gene Expression Regulation; Humans; Mice; Peptide Fragments; Peptidyl-Dipeptidase A	2008
Research profile. Places in the heart. Pinpointing the cause of cardiovascular complications. Diabetes forecast, 2007, Volume: 60, Issue:13 Topics: Angiotensin II; Cardiovascular Diseases; Diabetic Angiopathies; Humans; Insulin Resistance	2007
Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts. Endocrinology, 2008, Volume: 149, Issue:8 Topics: Angiotensin II; Animals; Antihypertensive Agents; Body Weight; Captopril; Cardiovascular Diseases; Drug Evaluation, Preclinical; Glucose; Heart; Insulin; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Myocardium; Obesity; Organ Culture Techniques; Organ Size; Oxygen Consumption; Signal Transduction	2008
Angiotensin and asymmetric fetal growth. Lancet (London, England), 1995, Sep-23, Volume: 346, Issue:8978 Topics: Adult; Angiotensin II; Angiotensinogen; Animals; Birth Weight; Cardiovascular Diseases; Cephalometry; Eclampsia; Embryonic and Fetal Development; Female; Humans; Hypertension; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular	1995
Osteopontin expression in cardiovascular diseases. Annals of the New York Academy of Sciences, 1995, Apr-21, Volume: 760 Topics: Angiotensin II; Animals; Arteries; Cardiovascular Diseases; Cell Adhesion; Fibrosis; Gene Expression; Inflammation; Integrins; Kidney; Macrophages; Muscle, Smooth, Vascular; Osteopontin; Rats; Receptors, Cytoadhesin; RNA, Messenger; Sialoglycoproteins; Time Factors; Wound Healing	1995
Angiotensin and the Heart. Symposium proceedings. Hamburg, October 22-24, 1992. Basic research in cardiology, 1993, Volume: 88 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Humans	1993
Cardiovascular remodeling and its correction: toward a comprehensive strategy. The American journal of medicine, 1993, Apr-23, Volume: 94, Issue:4A Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cilazapril; Humans; Hypertension	1993
Oxidative stress produced by angiotensin too. Implications for hypertension and vascular injury. Circulation, 1997, Feb-04, Volume: 95, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Free Radicals; Humans; Hypertension; Oxidative Stress; Superoxides	1997
Elevated albumin excretion in nonmodulating essential hypertensive patients. Nephron, 1997, Volume: 76, Issue:3 Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Drug Resistance; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Phenotype; Renin; Risk Factors; Sodium, Dietary	1997
Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 32, Issue:3 Topics: Angiotensin II; Animals; Autocrine Communication; Cardiovascular Diseases; Carotid Arteries; Carotid Artery Injuries; Cells, Cultured; Cytokines; Endothelium, Vascular; Hepatocyte Growth Factor; Humans; Male; Muscle, Smooth, Vascular; Polymerase Chain Reaction; Rats; Rats, Inbred WKY; Transforming Growth Factor beta; Vasoconstrictor Agents	1998
Historical evolution of angiotensin II receptor blockers: therapeutic advantages. Journal of the American Society of Nephrology : JASN, 1999, Volume: 10 Suppl 12 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiovascular Diseases; History, 19th Century; History, 20th Century; Humans; Hypertension; Renin-Angiotensin System	1999
State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:4 Pt 2 Topics: Angiotensin I; Angiotensin II; Animals; Cardiovascular Diseases; Cell Division; Humans; Muscle, Smooth, Vascular; Peptide Fragments	1999
[Clinical characteristics and follow-up of patients attending a hospital hypertension clinic. 10-year experience]. Anales de medicina interna (Madrid, Spain : 1984), 1999, Volume: 16, Issue:10 Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Data Interpretation, Statistical; Diabetes Complications; Diuretics; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Obesity; Outpatients; Risk Factors; Time Factors	1999
Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2000, Volume: 14, Issue:2 Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Cardiovascular Diseases; Endothelium, Vascular; Hemodynamics; Image Processing, Computer-Assisted; Immunohistochemistry; In Vitro Techniques; Male; Nitrates; Nitroprusside; Phenylephrine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Renin; Tyrosine; Vasoconstriction	2000
Effect of ramipril on cardiovascular events in high-risk patients. The New England journal of medicine, 2000, Jul-06, Volume: 343, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans	2000
[Pathophysiological roles of angiotensin in the pathogenesis of hypertension and cardiovascular remodeling]. Rinsho byori. The Japanese journal of clinical pathology, 2000, Volume: 48, Issue:10 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Humans; Hypertension; Mice; Mice, Knockout; Receptor Cross-Talk; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin	2000
Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:2 Pt 2 Topics: Aldosterone; Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Body Weight; Cardiovascular Diseases; Fibroblast Growth Factor 2; Heart; Immunohistochemistry; Mineralocorticoid Receptor Antagonists; NF-kappa B; Organ Size; Platelet-Derived Growth Factor; Rats; Receptors, Mineralocorticoid; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Tetrazoles; Transcription Factor AP-1; Transforming Growth Factor beta; Valine; Valsartan	2001
Role of reactive oxygen species in angiotensin ii signaling : the plot thickens. Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:4 Topics: Angiotensin II; Cardiovascular Diseases; Humans; Muscle, Smooth, Vascular; Reactive Oxygen Species; Receptors, Angiotensin; Signal Transduction	2001
Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:4 Topics: Angiotensin II; Cardiovascular Diseases; Cell Adhesion Molecules; Cell Communication; Cytokines; Endothelium, Vascular; Enzyme Activation; Homeostasis; Humans; Inflammation; Models, Biological; Nitric Oxide; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Risk Factors	2001
Pressure, platelets, and plaque: the central role of angiotensin II in cardiovascular pathology. Introduction. The American journal of cardiology, 2001, Apr-19, Volume: 87, Issue:8A Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Humans; Renin-Angiotensin System; Serine Endopeptidases	2001
Pressure, platelets, and plaque: the central role of angiotensin II in cardiovascular pathology. Concluding comment. The American journal of cardiology, 2001, Apr-19, Volume: 87, Issue:8A Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiovascular Diseases; Fibrinolysis; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Renin-Angiotensin System; Tetrazoles	2001
Renin-angiotensin system in human failing hearts: message from nonmyocyte cells to myocytes. Circulation research, 2001, May-11, Volume: 88, Issue:9 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Cardiovascular Diseases; Heart Ventricles; Humans; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger	2001
Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circulation research, 2001, May-11, Volume: 88, Issue:9 Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensinogen; Cardiomyopathy, Dilated; Cardiovascular Diseases; Chymases; Endothelin-1; Gene Expression; Gene Expression Regulation; Heart Ventricles; Immunohistochemistry; In Situ Hybridization; Insulin-Like Growth Factor I; Iodine Radioisotopes; Myocardial Ischemia; Myocardium; Peptidyl-Dipeptidase A; Platelet-Derived Growth Factor; Protein Precursors; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Serine Endopeptidases; Ventricular Function, Left	2001
Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation. Journal of hypertension, 2001, Volume: 19, Issue:6 Topics: Acetylcysteine; Aldehydes; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Cell Division; Cells, Cultured; DNA; Drug Synergism; Flavonoids; Humans; Hydrogen Peroxide; Lipoproteins, LDL; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Probucol; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Tyrphostins	2001
Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Circulation, 2001, Jul-31, Volume: 104, Issue:5 Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cardiovascular Diseases; CD4 Antigens; CD8 Antigens; Collagen; Fibroblast Growth Factor 2; Fibronectins; Gene Expression Regulation; Heart; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Interleukin-6; Male; Myocardium; NF-kappa B; Oligonucleotides; Protein Binding; Pyridines; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Survival Analysis; Survival Rate; Transcription Factor AP-1	2001
Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation, 2002, Jan-01, Volume: 105, Issue:1 Topics: Adrenal Glands; Adrenomedullin; Angiotensin II; Animals; Blood Pressure; Cardiovascular Diseases; Coronary Vessels; Female; Genotype; Lung; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADH, NADPH Oxidoreductases; NADPH Oxidase 2; NADPH Oxidases; Peptide Fragments; Peptides; Phosphoproteins; Proteins; Reactive Oxygen Species; Sodium, Dietary; Time Factors; Tyrosine	2002
Comparative effects of the dual ACE-NEP inhibitor MDL-100,240 and ramipril on hypertension and cardiovascular disease in endogenous angiotensin II-dependent hypertension. American journal of hypertension, 2002, Volume: 15, Issue:2 Pt 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Aorta; Benzazepines; Blood Pressure; Body Weight; Cardiovascular Diseases; Hypertension; In Vitro Techniques; Male; Neprilysin; Organ Size; Pyridines; Ramipril; Rats; Vasoconstriction	2002
Phosphodiesterase inhibition: erectile dysfunction is only part of the story. International journal of clinical practice, 2002, Volume: 56, Issue:4 Topics: Angiotensin II; Carbolines; Cardiovascular Diseases; Delayed-Action Preparations; Erectile Dysfunction; Humans; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil	2002
[Angiotensin loading test]. Nihon rinsho. Japanese journal of clinical medicine, 1979, Jun-29, Volume: Suppl Topics: Angiotensin II; Blood Pressure; Cardiovascular Diseases; Heart; Humans	1979
Aids in the diagnosis of hypertension. Angiology, 1977, Volume: 28, Issue:8 Topics: Aldosterone; Angiotensin II; Cardiovascular Diseases; Diuretics; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Renin	1977
[Further observations on the cortisonic and aldosterone potentiation of the action of angiotensin in man]. Minerva medica, 1967, Apr-28, Volume: 58, Issue:34 Topics: Adult; Aldosterone; Angiotensin II; Betamethasone; Blood Pressure; Cardiovascular Diseases; Drug Synergism; Female; Humans; Male; Prednisolone	1967
[Effect of hypertension on the renin-aldosterone system, renal circulation, glomerular filtration and electrolyte excretion in patients with chronic circulatory insufficiency]. Kardiologiia, 1970, Volume: 10, Issue:4 Topics: Adrenal Glands; Aldosterone; Angiotensin II; Blood Circulation; Calcium; Cardiovascular Diseases; Chemoreceptor Cells; Chlorides; Diuresis	1970
[The treatment of heart and circulatory disorders. 1. Circulatory drugs]. Tierarztliche Praxis, 1973, Volume: 1, Issue:3 Topics: Acridines; Angiotensin II; Animals; Blood Pressure; Caffeine; Cardiovascular Diseases; Cardiovascular System; Dog Diseases; Dogs; Epinephrine; Norepinephrine; Octopamine; Peristalsis; Theophylline; Vasopressins	1973